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Physical Activity and Maternal and Neonatal Outcomes in Obese Pregnant Women 
by 
Rachel Ann Tinius 
Doctor of Philosophy in Movement Science  
Washington University in St. Louis, 2015 
Dr. W. Todd Cade, Chairperson 
 
Maternal obesity and physical inactivity during pregnancy are independently associated with 
unfavorable maternal and neonatal metabolic outcomes. Previous research in non-gravid adults 
suggests physical activity provides protection from many chronic diseases irrespective of body 
weight.  The primary purposes of this dissertation were to determine the impact of obesity on 
maternal metabolic health (lipid metabolism, inflammation, insulin resistance) and neonatal 
metabolic health (adiposity, inflammation, insulin resistance), and to determine if adverse 
maternal and neonatal metabolic health is improved in obese pregnant women who are 
physically active during pregnancy compared to sedentary obese women. The secondary purpose 
of this dissertation was to examine the relationships between maternal and neonatal metabolic 
health.   
 
Three groups of pregnant women were compared between 32 and 37 weeks gestation (N=50). 
Groups consisted of: 1) lean women, 2) obese sedentary women, and 3) obese physically active 
women. Body composition (skinfold anthropometry), physical fitness levels (submaximal cycle 
xiv 
 
test), and physical activity levels (accelerometry) were assessed. Maternal plasma markers of 
insulin resistance (Homeostatic Model Assessment-Insulin Resistance (HOMA-IR)) and 
systemic inflammation (C – reactive protein) were measured at rest. Lipid oxidation rate and 
lipolysis were measured at baseline, during a 30-minute bout of low-intensity exercise, and 
during a 1-hour recovery period. Cord blood was collected at parturition to measure neonatal 
plasma insulin resistance, inflammation, and free fatty acid concentration. Neonatal body 
composition was measured 24-48 hours postpartum via skinfold anthropometry and air 
displacement plethysmography.  
 
In Chapter 2, maternal and neonatal outcomes were compared between lean and obese pregnant 
women. Obese pregnant women had higher maternal inflammation, insulin resistance, and lipid 
oxidation rates. Maternal lipid oxidation rate and inflammation were positively correlated. 
Maternal inflammation was positively correlated to insulin resistance and blood pressure. 
Therefore, lipid metabolism may be contributing to inflammation and subsequent insulin 
resistance and hypertension in obese pregnant women.  
 
In Chapter 3, maternal and neonatal outcomes were compared between obese sedentary and 
obese physically active pregnant women. Physically active obese women had lower systemic 
inflammation compared to sedentary obese women; thus, regular physical activity may improve 
inflammation in obese pregnant women.  
 
In Chapter 4, the relationships between maternal and neonatal metabolic outcomes were 
examined. There were no correlations between maternal and neonatal metabolic outcomes across 
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all women in the study. Several relationships between maternal and neonatal outcomes were 
found when comparing lean or obese women separately, which suggests that the mechanisms 
linking maternal and neonatal metabolic health are complex and potentially BMI-dependent.  
 
In Chapter 5, the relationship between intensity of physical activity and maternal inflammation 
was examined. Low-intensity physical activities had the strongest negative correlation to 
systemic inflammation. Data from Chapter 5 also suggest that small daily increases in low-
intensity physical activities may be enough of a stimulus to elicit clinically meaningful 
reductions in inflammation. Thus, pregnant women should be encouraged to participate in low-
intensity physical activities in order to reduce their systemic inflammation and improve their 
long-term health.  
 
Overall, results from this dissertation project suggest that obesity during pregnancy has 
unfavorable implications for maternal metabolic health. However, a physically active lifestyle 
might mitigate these alterations, particularly maternal systemic inflammation. Pregnant women 
of all body weights should be encouraged to participate in daily physical activity, even low-
intensity activity, in order to improve their health and the future health of their offspring.
1 
 
Chapter 1: Background and Significance 
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1.1  Maternal Obesity during Pregnancy- The Public 
Health Problem 
The obesity epidemic is an international public health crisis. Concurrent with record rates of 
obesity in the general population is the increasing prevalence of maternal obesity. Maternal 
obesity has increased 60% in the past two decades1 with nearly 1 in 3 women now entering 
pregnancy obese2. Maternal obesity increases the risk for a wide-array of maternal complications 
including miscarriages3,4, preterm delivery4,5, excessive gestational weight gain6,7, gestational 
diabetes8,9, preeclampsia and other hypertensive disorders5,10, prolonged labor11,  delivery 
complications12-14, and medically-necessary caesarean deliveries5,15.  In addition, maternal 
obesity contributes to a considerable number of short and long-term neonatal outcomes including 
undetected anomalies or malformations from reduced sensitivity on ultrasounds16-18, acute 
trauma during delivery13,14, attention-deficit and emotional disorders19, neural tube defects20,21 , 
excess adiposity1,22, and  insulin resistance23,24.   
 
In addition to the serious health implications, obesity during pregnancy has a profound effect on 
health care costs as the average total costs (practitioner visits, medications, inpatient and 
outpatient visits) are estimated to be nearly 40% higher in obese women when compared to lean 
women25. The increasing number of women entering pregnancy obese is a significant health 
problem; thus, understanding the mechanisms by which obesity induces unfavorable outcomes as 
well as establishing potential therapeutic targets is critical in order to improve health problems 
and reduce costs associated with obesity during pregnancy. 
 
3 
 
1.1.1  Fetal Origins Hypothesis 
Maternal obesity causes many physiologic changes that increase the risk of poor maternal health 
during pregnancy and postpartum. Unfavorable physiologic changes may also play a crucial role 
in adverse fetal programming leading to unfavorable neonatal outcomes with long-term health 
implications1,13,26,27. One of the primary hypotheses attempting to explain the connection 
between maternal and neonatal physiology is the “fetal origins hypothesis”28,29.  The “fetal 
origins hypothesis” suggests that the intrauterine metabolic environment plays a crucial role in 
neonatal “programming”; thus, the origins of adult health diseases such as obesity, 
cardiovascular disease, and diabetes may be predetermined by in utero exposures28,29.  
Understanding the implications of obesity on maternal health, the intrauterine metabolic 
environment, and neonatal health is important as obesity may be the most common health risk 
for the developing fetus1. It is critical that metabolic alterations in obese pregnant women are 
identified in order to develop interventions that modulate the factors contributing to adverse 
pregnancy outcomes. In particular, maternal lipid metabolism, insulin resistance, and 
inflammation may be altered in obese pregnant women, and these factors may play a role in the 
“programming” of neonatal adiposity, insulin resistance, and inflammation. 
 
1.1.2 Lipid Metabolism 
 
Lipid metabolism in non-gravid obese adults 
Two aspects of lipid metabolism are lipid oxidation rate and lipolysis, which are closely related 
to each other during resting and exercise conditions30. Lipid oxidation rate is the rate at which 
lipids are oxidized as a source of energy, while lipolysis is the breakdown of adipose tissue 
stores (hydrolysis of triglycerides into glycerol and free fatty acids which are then released into 
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the bloodstream). In obesity, lipid metabolism is altered which may contribute to unfavorable 
metabolic perturbations such as insulin resistance, oxidative stress, and inflammation31,32.   
 
Previous data on lipid oxidative capacity in obesity are equivocal; some studies demonstrate 
higher lipid oxidation rate in obesity33,34, while others show lipid oxidation rate is down-
regulated35-37. For example, Berggren et al. found lower fatty acid oxidation rate in obese 
individuals and attributed it to a defect in the ability to properly oxidize lipids in skeletal 
muscle37. On the contrary, Goodpastor et al. determined that during acute low-intensity exercise 
(i.e. when lipid metabolism is stimulated), lipid oxidation rates appear to be higher in obese men 
compared to lean men33. Altered rates of lipid oxidation are important as these rates are 
intricately related to inflammation and glucose metabolism. In non-gravid individuals, lipid 
oxidation signals pathways that initiate an inflammatory response31,38, demonstrating a 
connection between lipid metabolism, inflammation and cardiovascular disease risk. Similarly, 
increased lipolysis may lead to higher plasma free fatty acid concentration and glucose 
intolerance in non-gravid adults39; thus providing a connection between lipid metabolism and 
insulin resistance.  
 
Increased lipid oxidation may also lead to excess generation of reactive oxygen species, which 
are known byproducts of lipid oxidation32. Bell et al. concluded that incomplete fatty acid 
oxidation is increased and complete fatty acid oxidation is decreased in muscle cells from obese 
individuals when compared to muscle cells from lean individuals40. Thus, incomplete, partial 
oxidation is increased in obesity, but complete, efficient oxidation is decreased40. This finding 
may explain the equivocal findings on lipid oxidation rates in obesity. 
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The potential impact of incomplete maternal lipid oxidation on obese pregnant women could be 
substantial as it will produce excess reactive oxygen species leading to a state of oxidative stress. 
In non-gravid adults, oxidative stress is associated with inflammation, damage to vascular cell 
walls, high blood pressure, cardiovascular disease, cancer, neurodegenerative disease, hepatic 
disease, decreased aerobic capacity, and physiologic aging41-46. In addition, oxidative stress is 
believed to be a deleterious factor leading to insulin resistance, beta-cell dysfunction, impaired 
glucose tolerance, and ultimately type 2 diabetes mellitus47-49. Moreover, non-gravid obese adults 
exhibit increased systemic oxidative stress when compared to normal-weight individuals50. It 
appears that obesity-induced oxidative stress may be a significant causal factor in the 
development of many obesity-related disease states in adults, particularly insulin resistance and 
inflammation45,48,49,51. Because reactive oxygen species are a by-product of inefficient lipid 
metabolism, higher lipid oxidation rates may contribute to a pathological metabolic process that 
can ultimately lead to inflammation and insulin resistance and contribute to adverse metabolic 
health in obese populations.  
 
Maternal lipid metabolism in obese women during pregnancy 
A careful understanding of maternal lipid metabolism during pregnancy is important as maternal 
lipids are believed to play a major role in fetal development52,53. Lipid oxidation and lipolytic 
rates are elevated in normal-weight pregnant women compared to non-pregnant women, 
particularly near then end of gestation as a mechanism to spare glucose for the fetus52-54. 
Maternal lipid oxidation and lipolysis in obese women during pregnancy and their relationships 
to unfavorable neonatal outcomes have not been previously studied. Thus, the influence of 
maternal obesity on lipid metabolism during pregnancy is the next logical, and so far unexplored, 
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step in examining the role of altered maternal substrate metabolism in adverse maternal and 
neonatal health outcomes in this population.  The finding of altered lipid metabolism during 
pregnancy in obese women may suggest that unfavorable metabolic adaptations contribute to 
maternal, and perhaps neonatal, inflammation and insulin resistance (as both inflammation and 
insulin resistance are related to alterations in lipid metabolism in obese non-gravid adults31,39).  
 
Animal model data suggest impaired maternal whole-body fatty acid oxidative capacity in 
obesity may precede development of offspring adiposity and its associated co-morbidities26. 
Understanding maternal lipid metabolism in obese women during pregnancy might uncover 
important information regarding metabolic dysregulation and how it impacts maternal and 
neonatal outcomes in this population. In addition, the knowledge gained may inform future 
interventions as lipid oxidation rate and lipolysis are physiologic mechanisms that could 
eventually be targeted for potential therapies as both can be impacted by diet and exercise55,56.  
 
1.1.3  Inflammation  
 
Inflammation in non-gravid obese adults 
Acute inflammation is an important and necessary biological response to noxious stimuli57. 
Inflammation stimulates an immune response that can combat acute threats to the body’s 
homeostasis. However, sustained, inappropriate inflammatory responses can have detrimental 
effects on health57. 
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It is well-established that obesity is associated with low-grade, chronic, systemic inflammation58. 
Low-grade systemic inflammation secondary to obesity plays an important role in the 
pathogenesis of many chronic diseases including metabolic syndrome, cardiovascular disease, 
diabetes, and hypertension59. C-reactive protein (CRP) is the most commonly utilized marker of 
inflammation, and it has been associated with adiposity, hyperinsulinemia, insulin resistance, 
low HDL concentrations, and cardiovascular disease60-62. CRP has been distinguished as the 
most important inflammatory biomarker for cardiovascular disease and cardiovascular disease 
risk63-65.  
 
Inflammation in obese women during pregnancy 
Maternal markers of inflammation, including CRP, are elevated in normal physiologic 
pregnancy66. Therefore, the addition of obesity  leads to further elevated levels of systemic 
inflammation during pregnancy67. Indeed, Catalano et al. found that obese pregnant women have 
higher levels of CRP when compared to normal-weight pregnant women68. It is hypothesized 
that the higher levels of inflammation in obese pregnant women may contribute to the well-
established increased risk for the development of metabolic complications during pregnancy 
such as insulin resistance and hypertension. In fact, Ozgu-Erdinc et al. found that first trimester 
CRP levels are correlated with later development of gestational diabetes69, suggesting maternal 
inflammation may be predictive of maternal insulin resistance later in pregnancy. Similarly, early 
pregnancy maternal inflammation has also been linked with the development of preeclampsia70.  
Higher maternal inflammation during pregnancy may also contribute to increased maternal risk 
for future development of metabolic syndrome, insulin resistance, diabetes, hypertension, and 
cardiovascular disease71.   
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Interestingly, maternal inflammatory changes during pregnancy are believed to extend into the 
placenta, suggesting that the fetus of a woman with excessive inflammation is exposed to an 
inflammatory environment during development72.  This exposure might predispose neonates to 
have a higher risk for the development of metabolic disease in adulthood73,74. In support, 
Catalano et al. found that obese pregnant women had higher maternal and umbilical cord blood 
concentrations of inflammatory markers (IL-6 and CRP) compared to lean women68. This 
finding also suggests maternal inflammation may directly contribute to neonatal inflammation.  
Overall, maternal obesity and subsequent inflammation might contribute to poor outcomes in 
pregnant women and their offspring. The relationships between maternal inflammation and 
neonatal metabolic outcomes are unclear. It is critical these relationships are established in order 
to understand perinatal development of metabolic disease and thus, inform future intervention 
strategies.  
 
1.1.4  Insulin Resistance 
 
Insulin resistance in obese non-gravid adults 
 
Insulin resistance reflects an impairment in the tissues’ (e.g. skeletal muscle, liver, adipose 
tissue) ability to respond to the effects of insulin, which impairs how well the tissue is able to 
clear glucose.75 When tissues become insulin resistant, the pancreatic beta-cells secrete higher 
amounts of insulin until they become deficient76. The combination of insulin resistance and beta-
cell deficiency leads to dysregulation of blood glucose.  
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Obesity is the most common risk factor for impaired insulin action75 and the development of type 
2 diabetes77. Adipose tissue, which is abundant in obesity, releases a number of factors that 
contribute to the development of insulin resistance78. Insulin resistance has serious consequences 
as it precedes the development of type 2 diabetes and cardiovascular disease79.   
 
Insulin resistance in obese women during pregnancy 
Physiologic insulin resistance occurs during normal pregnancies as the result of human placental 
lactogen, elevated lipids, and the release of several cytokines75. However, when a pregnant 
woman is also obese, insulin resistance is elevated further which leads to poor outcomes in 
pregnant women and their neonates8,68. Insulin resistance can develop into a diagnosis of 
gestational diabetes, which is defined as glucose intolerance with onset or first recognition 
during pregnancy. Further, obese and morbidly obese pregnant women are 2.6 and 4 times more 
likely to develop insulin resistance and gestational diabetes, respectively5,9. Insulin resistance 
and gestational diabetes can be very problematic to maintaining a healthy pregnancy9.  Women 
who develop gestational diabetes are at an increased risk of adverse perinatal, maternal and 
neonatal outcomes, recurrence of gestational diabetes in subsequent pregnancies, as well as 
development of type 2 diabetes postpartum8,80,81.  
 
Interestingly, insulin resistance in obese pregnant women appears to translate into the offspring. 
Neonates from overweight and obese women have impaired insulin action compared to neonates 
of normal-weight women22. However, this has not been well-studied in obese pregnant women. 
The contribution of maternal metabolism, including insulin resistance, to fetal programming and 
neonatal outcomes in obese pregnant women remains unclear. 
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1.1.5  Neonatal Adiposity 
Maternal obesity increases the risk for giving birth to infants with excess adiposity1,22,82  as 
maternal obesity is believed to play a significant role in the development of fetal overgrowth83.  
Obesity in childhood is a strong predictor of adult adiposity, thus, pre-pregnancy maternal 
obesity may predispose neonates to future obesity84-86. In addition to the increased risk for 
obesity into childhood and adulthood, offspring of obese women are also at elevated risk for 
future development of obesity-related disease states such as hypertension, insulin resistance, 
dyslipidemia, and cardiovascular disease9,82,87. Neonatal macrosomia itself is an independent risk 
factor for adult metabolic syndrome88; thus, the prevention of macrosomia and excessive 
neonatal adiposity  is vital to combatting the generational cycle of obesity and its associated 
comorbidities.  
 
1.2 Physical Inactivity during Pregnancy- The Public 
Health Problem 
Pregnant women are less physically active than their non-gravid counterparts89,90.  Only 23% of 
pregnant women exercise in accordance with guidelines set by the American Congress of 
Obstetricians and Gynecologists91 despite strong evidence supporting the physiological benefits 
to pregnant women and their neonates92.  
 
1.2.1  Maternal Benefits of Physical Activity during Pregnancy 
Physically active women report fewer pregnancy-related problems such as insomnia, anxiety, 
nausea, heartburn, leg cramps, round ligament pain, and low back pain93,94, with the greatest 
relief seen in those who remain active during the entire nine months of gestation94. Exercise also 
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improves depressive symptoms, mood, and self-image in pregnant women95,96.  Active pregnant 
women also demonstrate improved fitness, aerobic capacity, exercise performance, and overall 
well-being15,97-99.   
 
Physical activity during pregnancy can also improve the labor and delivery process. Active 
pregnant women are at decreased risk for abdominal and operative vaginal deliveries15,100-102. 
Similarly, aerobic and non-aerobic exercise training programs are associated with shorter active 
labors100,101, although this topic is controversial as some studies have found no difference in 
duration of labor between active and inactive pregnant women96,98,103,104. Physical activity during 
pregnancy also improves recovery following a vaginal delivery as Price et al. found women who 
were active during pregnancy were able to return to pre-pregnancy household activities nearly 
twice as quickly after delivery15.  
 
Not only can exercise reduce symptoms of pregnancy, incidence of operative delivery, and 
speed-up recovery time, but physical activity can help limit weight gain during pregnancy. It is 
well-documented that women who engage in physical activity (e.g. exercise) during pregnancy 
gain less weight100,105,106.  Excessive gestational weight gain is the strongest risk factor for 
maternal postpartum weight retention, and gestational weight gain is related to many adverse 
maternal and neonatal outcomes107-113. Additionally, physically active women have a decreased 
risk of developing preeclampsia114-116. Therefore, the benefits of physical activity during 
pregnancy are substantial. 
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Maternal physical activity and maternal lipid metabolism during pregnancy 
 
In non-gravid adults, physical activity increases the efficiency of lipid metabolism55. More 
specifically, endurance exercise training increases the capacity for oxidative metabolism of fatty 
acids and carbohydrates117. In obese non-gravid individuals, skeletal muscle lipid oxidation is 
deficient, but exercise can correct this impairment37.  
 
The impact of physical activity during pregnancy on maternal lipid metabolism and its 
relationship to maternal and neonatal metabolic health has not been studied in normal-weight or 
obese women. Because lipid metabolism (particularly pathways that target lipid oxidation) has 
potential to be a future therapeutic target, studies in this area are needed to inform future 
interventions. 
  
Maternal physical activity and maternal insulin resistance 
Previous studies suggest that maternal physical activity during pregnancy can prevent the 
development of gestational diabetes118-120; however, the impact of physical activity on gestational 
diabetes is controversial as a Cochrane review suggests that evidence supporting the role of 
physical activity in preventing gestational diabetes is insufficient121.   
 
In non-gravid adults, physical activity reduces insulin resistance122, and this effect happens 
irrespective of weight loss123 . Similarly, insulin sensitivity is improved in normal-weight 
pregnant women who are active when compared to their inactive counterparts124. Physical 
activity-associated improvements in insulin resistance might also occur in obese pregnant 
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women as van Poppel et al. reported lower insulin resistance in active overweight and obese 
pregnant women compared to inactive overweight and obese women125. It is important to 
consider the implications of physical activity on obese women as they are at the highest risk for 
insulin resistance, gestational diabetes, and future type 2 diabetes mellitus; thus, physical 
activity-related improvements in insulin resistance may have the greatest benefit in obese 
women.  
  
Maternal physical activity and maternal inflammation 
In non-gravid adults, systemic inflammation (i.e. plasma CRP) is inversely related to physical 
activity levels, suggesting that physical activity may reduce inflammation126.  Further, exercise 
training lowers systemic inflammation in non-gravid obese women127.  In pregnancy, physical 
activity levels before and during pregnancy have been shown to reduce plasma CRP 
concentrations128,129.  To our knowledge, the impact of physical activity during pregnancy on 
maternal and neonatal CRP levels has not been studied in at-risk obese women. One prior study 
examined the relationship between physical activity during pregnancy and maternal plasma CRP 
concentration in a combination of overweight and obese women, and they found no 
association130. However, we believe our study design will better allow us to assess the role of 
physical activity on maternal and neonatal plasma inflammation in exclusively obese pregnant 
women. 
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1.2.2 Neonatal Benefits of Physical Activity during Pregnancy 
 The benefits of maternal physical activity during pregnancy on the fetus begin in utero, as 
regular, weight-bearing maternal exercise is associated with placental growth and volume131. 
Price et al. found that there is less incidence of acute neonatal stress at delivery for neonates of 
active women15. Maternal physical activity during pregnancy also has a positive influence on 
acute health as active women deliver neonates with higher Apgar scores102,132,133.  In addition, 
maternal physical activity may influence neurodevelopment as neonates born to active women 
have higher neurodevelopmental scores during the first four years of life134.  Interestingly, 
animal models have even shown that physical activity during pregnancy mitigates the risk for 
congenital heart disease in offspring of maternal obesity135. With maternal obesity and diabetes 
being well-established risk factors for congenital heart disease in the offspring136, the benefits of 
a physically active lifestyle on neonatal health outcomes among obese pregnant women are 
substantial. Clearly, the influence of maternal physical activity on neonatal health is widespread 
and may have a significant influence on the short and long-term health of the offspring. 
 
Maternal physical activity and neonatal adiposity  
 
Regular physical activity during pregnancy in normal-weight women is associated with the 
delivery of lighter and leaner infants106,133,137-140. Women who participate in moderate-to-high 
intensity exercise throughout their pregnancy have significantly smaller (albeit within a healthy 
range) babies106,133,139,140, and are less likely to have large-for-gestation-age neonates141. Large-
for-gestation-age neonates are at increased risk of shoulder dystocia, brachial plexus injury, 
skeletal injuries, meconium aspiration, perinatal asphyxia, hypoglycemia, and fetal death142-147. 
Most importantly, neonatal macrosomia (i.e. large-for-gestation-age) is an independent risk 
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factor for adult metabolic syndrome88.  Neonates born to active women have lower birth weights, 
and that nearly 70% of the difference in birth weight between neonates born to active versus 
inactive women can be attributed to neonatal fat mass133. In addition, late-pregnancy energy 
expenditure is associated with lower neonatal adiposity without reduced neonatal fat-free 
mass148. Further, physical activity during pregnancy appears not only to decrease neonatal weight 
and fat mass at birth, but it may also produce effects that last in childhood and adulthood. 
Mattran et al. concluded that higher physical activity levels during pregnancy were associated 
with lower toddler weights and lower weight-for-height ratios149.  Similarly, Mourtakos et al. and 
Clapp et al. suggest physical activity may have an impact on long-term body composition as 
maternal physical activity was related to offspring body composition at eight and five years of 
age, respectively150,151.  
 
The impact of physical activity on neonatal body composition in at-risk obese women is unclear. 
Hayes et al. found that active obese women delivered neonates with  lower abdominal 
circumferences compared to neonates of inactive obese pregnant women152; suggesting physical 
activity in obese pregnant women may reduce neonatal adiposity. However, abdominal 
circumference as a means of estimating neonatal body fat percentage is less accurate than air 
displacement plethysmography153.  
 
 
Maternal physical activity and neonatal insulin resistance 
The impact of maternal physical activity during pregnancy on neonatal insulin resistance has not 
been well-studied in normal-weight or obese women. In an animal model by Stanford et al., 
16 
 
exercise before and during pregnancy improved glucose tolerance and lowered serum insulin 
concentrations in offspring154.  Similarly, Carter et al. found that offspring born to dams who 
exercised during pregnancy had enhanced insulin sensitivity and improved glucose homeostasis 
as adult rats155. This suggests that maternal exercise may have short and long-term impacts on 
the offspring’s neonatal insulin resistance.   
 
Clearly, there is a lack of quality research assessing the impact of physical activity on neonatal 
metabolic health (e.g. insulin resistance) in humans, particularly in overweight and obese 
women. Studying offspring of obese women is important to designing future interventions as 
these women and their offspring may be at the highest risk for future diabetes development. With 
future obesity and diabetes development being significant public health concerns, exercising 
throughout pregnancy may play an important role on the long-term metabolic health of the 
offspring by reducing risk of obesity and diabetes later in life. 
 
Maternal physical activity and neonatal inflammation  
Maternal inflammatory changes during pregnancy are believed to extend into the placenta thus 
exposing the fetus to an inflammatory environment during development72.  The exposure to 
inflammation in utero might predispose the fetus to the development of metabolic disease in 
adulthood73,74. Indeed, Catalano et al. demonstrated that obese pregnant women had higher levels 
of inflammatory markers (IL-6 and CRP) in maternal and umbilical cord blood when compared 
to lean pregnant women68. This finding suggests a relationship between maternal and neonatal 
inflammation. Fortunately, maternal physical activity can reduce maternal inflammation during 
pregnancy128,129; however, it is unknown whether these reductions in maternal inflammation 
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translate into lower neonatal inflammation. The impact of physical activity on inflammation in 
obese pregnant women and their neonates is unknown and requires further study.  
 
1.3 Physical Activity during Pregnancy in Obese Women  
In summary, pre-pregnancy obesity increases the risk for unfavorable alterations in maternal 
lipid metabolism, insulin resistance, and inflammation. It also increases the risk for worse 
neonatal outcomes including excess adiposity, higher insulin resistance, and higher neonatal 
inflammation. In non-gravid populations, exercise improves lipid metabolism, decreases insulin 
resistance, and decreases inflammation. In normal-weight pregnancies, exercise also improves 
maternal lipid metabolism, insulin resistance, and inflammation, as well as neonatal adiposity. 
However, the role of a physically active lifestyle on metabolic outcomes in obese pregnant 
women has not been well-studied. Understanding the intrauterine metabolic environment and its 
impact on short and long-term maternal and neonatal metabolic health in obese pregnant women 
is critical as obese women are at the highest risk for poor pregnancy outcomes with subsequent 
long-term implications. 
 
Previous research in non-gravid adults suggests that the presence of multiple comorbidities is 
more strongly correlated with physical inactivity than overweight/obesity156,157. Thus, the overall 
purpose of this dissertation is to determine if maternal physical activity during pregnancy can 
mitigate poor maternal and neonatal metabolic outcomes (i.e. maternal lipid metabolism, insulin 
resistance, inflammation, and neonatal adiposity, insulin resistance, and inflammation) 
commonly observed in obese women.  It is important that these relationships are established in 
order to develop interventions that modulate metabolic factors contributing to adverse outcomes 
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in obese pregnant women. Figure 1.1 summarizes Chapter 1 by outlining risks associated with 
maternal obesity and benefits of maternal physical activity, and their impacts on maternal and 
neonatal long-term health.  
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Figure 1.1 Summary of maternal and neonatal risks of obesity and benefits of physical activity 
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1.4 Purposes and Specific Aims 
The primary purposes of this dissertation are to (1) compare maternal lipid metabolism, 
maternal inflammation, maternal insulin resistance, and neonatal metabolic health between lean 
and obese pregnant women, (2) determine if a physically active lifestyle during pregnancy is 
associated with improved maternal lipid metabolism, lower maternal inflammation, lower 
maternal insulin resistance, and better neonatal metabolic health in obese women during late 
pregnancy, and to (3) determine the relationships between maternal and neonatal metabolic 
health. Figure 1.2 outlines the aims, groups, and outcome variables for Specific Aims 1-3 in a 
dissertation project summary. Specific Aim 4 is a secondary analysis and is not shown in Figure 
1.2.  
 
Specific Aim 1 (Chapter 2): To compare maternal lipid kinetics during rest and low-intensity 
exercise, maternal systemic inflammation, and neonatal metabolic outcomes between lean and 
obese women during late pregnancy.  
Hypothesis 1a: Maternal lipid oxidation rate and lipolysis will be higher in obese women 
compared to lean women during rest and low-intensity exercise.  
Hypothesis 1b: Systemic inflammation will be higher in obese women compared to lean 
women. 
Hypothesis 1c: Neonates of obese women will have higher adiposity, higher systemic 
inflammation, and higher insulin resistance compared to neonates of lean women.  
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Specific Aim 2 (Chapter 3): To compare maternal lipid kinetics during rest and low-intensity 
exercise, maternal systemic inflammation, and neonatal metabolic outcomes between physically 
active and sedentary obese pregnant women during late pregnancy. 
Hypothesis 2a: Maternal lipid oxidation rate and lipolysis will be lower in active obese women 
compared to sedentary obese women.  
Hypothesis 2b:  Systemic inflammation will be lower in active obese women compared to 
sedentary obese women.  
Hypothesis 2c:  Neonates of physically active obese women will have lower adiposity, lower 
systemic inflammation, and lower insulin resistance than neonates of sedentary obese women.  
 
Specific Aim 3 (Chapter 4): To determine the relationships between maternal lipid kinetics, 
maternal insulin resistance, and maternal systemic inflammation, and neonatal metabolic 
outcomes (adiposity, insulin resistance, and inflammation).  
Hypothesis 3a:  Higher maternal lipid oxidation rate and lipolysis will be associated with higher 
neonatal adiposity, higher neonatal insulin resistance, and higher neonatal inflammation.  
Hypothesis 3b: Maternal insulin resistance will be positively correlated with neonatal insulin 
resistance.  
Hypothesis 3c: Maternal systemic inflammation will be positively correlated to neonatal 
systemic inflammation.  
 
 
Specific Aim 4 (Chapter 5):  To determine the relationship between intensity of physical 
activity and maternal inflammation.  
22 
 
Hypothesis 4a: Time spent sedentary will be positively correlated with maternal inflammation.  
Hypothesis 4b: Moderate intensity physical activity will have the strongest negative correlation 
to maternal inflammation when compared to light and lifestyle (low-intensity) physical activities.   
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Figure 1.2 Dissertation project summary for Specific Aims 1-3   
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2.1 Abstract  
 
Background: Inflammation is elevated in obese pregnant women and is associated with adverse 
maternal and neonatal outcomes. Maternal lipid metabolism and its relationships with maternal 
inflammation, insulin resistance and neonatal metabolic health are poorly understood in obese 
pregnant women.  
Methods: 18 lean (age: 26.1 ± 5.0 years, pre-pregnancy BMI: 21.5 ± 1.9 kg/m2) and 16 obese 
(age: 25.0 ± 4.8 years, pre-pregnancy BMI: 36.3 ± 4.3 kg/m2) women participated in this case-
control study during the third trimester of pregnancy.  Maternal plasma markers of insulin 
resistance (HOMA-IR) and inflammation (C-reactive protein (CRP)) were measured at rest, and 
lipid concentration and kinetics (lipid oxidation rate and lipolysis) were measured at rest, during 
a 30-minute bout of low-intensity (40% VO2peak) exercise, and during a recovery period. 
Umbilical cord blood was collected for measurement of neonatal plasma insulin resistance, 
inflammation, and lipid concentration. Neonatal body composition was measured via air 
displacement plethysmography.  
Results: Pregnant obese women had higher plasma CRP (9.1 ± 4.0 mg/L versus 2.3 ± 1.8 mg/L, 
p<0.001) and higher HOMA-IR (3.8 ± 1.9 versus 2.3 ± 1.5, p=0.009) compared to pregnant lean 
women. Obese women had higher lipid oxidation rates during recovery from low-intensity 
exercise (0.13 ±0.03g/min versus 0.11 ±0.04g/min, p=0.02) that was associated with higher 
maternal CRP (r=0.55, p=0.001).  Maternal CRP was positively associated with maternal 
HOMA-IR (r=0.40, p<0.02) and systolic blood pressure (r=0.40, p<0.02).  
Conclusions: Maternal lipid metabolism-associated inflammation may contribute to insulin 
resistance and higher blood pressure in obese women during pregnancy. 
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2.2 Introduction 
Maternal obesity is a significant public health concern in the United States as one in three 
women enter pregnancy obese1.  Maternal obesity is associated with increased risk of maternal 
complications including excessive gestational weight gain2,3, gestational diabetes4, preeclampsia 
and other hypertensive disorders5-8, and long-term maternal cardiovascular morbidity9.  Obesity 
during pregnancy also contributes to unfavorable offspring metabolic outcomes including excess 
adiposity10,11 and insulin resistance12. 
 
Obese women experience metabolic dysfunction during pregnancy including higher plasma 
inflammation and lower insulin sensitivity4,13,14. Inflammation and insulin resistance are not only 
interrelated, but also associated with adverse pregnancy outcomes13,15-19.  Mechanisms 
contributing to elevated maternal inflammation during pregnancy in obese women are not fully 
understood.  Evidence suggests that non-gravid, obese adults have elevated lipid oxidation rates 
at rest20 and during low-to-moderate intensity exercise21,22, and that excessive lipid oxidation is 
associated with higher inflammation23. Elevated maternal lipid oxidation during pregnancy in 
obese women might be contributing to increases in maternal inflammation and subsequent 
alterations in maternal metabolic health. In addition, alterations in maternal lipid metabolism 
might impact offspring health as maternal obesity contributes to a lipotoxic placental 
environment that may be associated with increased in utero markers of inflammation and altered 
fetal development24,25.  However, maternal lipid oxidation and its relationships with maternal and 
neonatal inflammation and metabolic health have not been previously examined.  
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The primary purposes of this study were to compare lipid oxidation and lipolysis during late 
pregnancy between obese and lean women, and to examine the relationships between maternal 
lipid metabolism, inflammation and insulin resistance. The secondary purpose was to compare 
neonatal metabolic outcomes (adiposity, inflammation, and insulin resistance) between neonates 
of lean and obese pregnant women. We hypothesized that obese pregnant women would have 
higher lipid oxidation rate and lipolysis, and these would be associated with higher maternal 
inflammation and insulin resistance. We also hypothesized that neonates born to obese women 
would have higher neonatal adiposity, inflammation, insulin resistance. The knowledge gained 
from this study may identify lipid metabolism as a mechanism contributing to maternal 
inflammation and a potential therapeutic target to reduce inflammation and insulin resistance in 
obese pregnant women.    
 
2.3 Methods 
 
2.3.1  Participants 
Thirty-four women participated in the study (lean: n=18, obese: n=16).  Women receiving 
prenatal care at the Women’s Health Center and Women’s Health Clinic at Barnes Jewish 
Hospital/Washington University between August 2013 and November 2014 were screened for 
inclusion. Approximately 350 women were screened, and 50 women who met all criteria with 
ongoing pregnancies were approached for participation late in their second trimester. Inclusion 
criteria included women ages 18-44 years, confirmed singleton viable pregnancy with no 
identified fetal abnormalities (as determined by routine anatomy ultrasound at 18-22 weeks), and 
pre-pregnancy BMI between 18.0 and 24.9 kg/m2 for the lean group or pre-pregnancy BMI 
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between 30 and 45 kg/m2 for the obese group. Exclusion criteria included: 1) multiple gestation 
pregnancy, 2) inability to provide voluntary informed consent,  3) self- reported use of illegal 
drugs (cocaine, methamphetamine, opiates),  4) current smoker who did not consent to cessation, 
5) current usage of daily medications by class: corticosteroids, beta-blockers (known to affect 
lipid metabolism) and anti-psychotics (known to alter insulin resistance and metabolic profiles), 
6) diagnosis of gestational diabetes in current pregnancy, history of gestational diabetes, pre-
pregnancy diabetes or prior macrosomic (>4500g) infant (each elevate the risk for gestational 
diabetes in the current pregnancy, or undiagnosed gestational diabetes), 7) history of heart 
disease, or 8) any other condition that would preclude exercise.  
 
2.3.2  Study Procedures 
All study procedures were performed at the Washington University School of Medicine Institute 
for Clinical and Translational Sciences Clinical Research Unit (CRU). All pregnant women 
participated in two maternal visits between 32 and 37 weeks gestation. Approval for this study 
was granted by the Institutional Review Board at Washington University (IRB ID: 201306109, 
NCT: NCT02039414).  
 
Maternal Visit #1 
Body composition was measured using skinfold anthropometry in order to determine maternal 
percent body fat. Body fat percentage was determined by pressing folds of the skin at seven sites 
with a caliper (Harpenden Skinfolds Caliper, Baty International, United Kingdom), recording 
skin thickness, and entering the data into a standardized equation that accounts for age as 
previously described26. Participants also completed the YMCA submaximal cycle test as 
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previously performed in order to predict cardiorespiratory fitness levels27.  National Institutes of 
Health’s Dietary History Questionnaire II was completed by each participant to determine 
potential differences in maternal diet28.  Previous literature demonstrates that dietary history 
questionnaires are valid and reproducible among pregnant populations29.  
 
Maternal Visit 2 
Approximately one week after Visit 1, subjects were admitted to the CRU the morning after an 
overnight fast. The night prior, subjects were instructed to consume a standardized meal 
consisting of 50% carbohydrates, 30% fats, and 20% protein. Upon admission to the CRU, 
height, weight, and vital signs were obtained. A catheter (IV) was placed in a hand vein and 
heated to 55 °C by using a thermostatically controlled box in order to obtain arterialized blood 
samples as previously described30. Participants kept their hand in the box throughout the entire 
study visit. Participants rested for approximately 30 minutes prior to measuring lipid oxidation 
rate using indirect calorimetry (True One 2400, Parvomedics, Sandy, UT). Participants laid 
supine while a canopy was placed over their head for 15 minutes to measure oxygen 
consumption and carbon dioxide production in order to determine lipid oxidation rate31.  After 
the initial indirect calorimetry measurement, a baseline blood collection was obtained. 
Participants then exercised continuously at approximately 40% of their predicted VO2peak (based 
on the YMCA submaximal cycle test) for 30 minutes. Lipid metabolism was examined via 
indirect calorimetry and plasma analysis during and after exercise because low-to-moderate 
intensity exercise stimulates both adipose tissue breakdown (i.e. lipolysis) and lipid oxidation, 
and low-to-moderate intensity exercise might mimic their daily activity levels (~3-5 METS, e.g. 
household chores, caring for other children, walking).  Exercise indirect calorimetry was 
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performed and blood was drawn at the 10, 20, and 30 minute time points of submaximal 
exercise. After exercise termination, participants returned to supine and blood was drawn 10, 30, 
and 60 minutes-post cessation of exercise (i.e. recovery). Indirect calorimetry was performed 30 
minutes post-exercise for 15 minutes as described for the baseline measurement.  
 
Sample Analyses and Calculations 
All samples were immediately placed on ice and plasma was separated by centrifugation within 
30 minutes of collection. Plasma samples were stored at -80◦ C until final analyses were 
performed. Blood samples for glucose were collected in heparinized tubes and analyzed 
immediately with an automated glucose analyzer (Yellow Springs Instruments Co, Yellow 
Springs, OH). Plasma insulin concentration was measured by electrochemiluminescence 
technology (Elecsys 2010, Roche Diagnostics, Indianapolis, IN). Fasting insulin and glucose 
levels were used to calculate the homeostatic model assessment-insulin resistance (HOMA-IR)32. 
The HOMA-IR is an index of insulin resistance that reflects fasting glucose concentration 
measured at the fasting insulin concentration. Inflammation was examined through high-
sensitivity C-reactive protein (CRP) and measured by immunoturbidimetric assay (Roach 
Diagnostics, Indianapolis, IN). Blood samples used to determine plasma free fatty acids were 
collected in tubes containing EDTA. Plasma free fatty acid concentrations were determined by 
enzymatic colorimetric assay (Wako Pure Chemical Industries, Osaka, Japan). Lipolysis was 
calculated by the area under the curve (AUC) for free fatty acids, as previously described33, from 
baseline to the end of the study period. A summary score to represent total lipid oxidation rate 
throughout the study period was determined by calculating the AUC using lipid oxidation rates 
from baseline, exercise, and recovery time points. Clinical lipid profiles including triglycerides, 
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total cholesterol, low-density lipoprotein, and high-density lipoprotein were also obtained at the 
CRU. 
 
Neonatal Measurements 
At parturition, neonatal birth weight was obtained. In addition, 44 mL of umbilical vein blood 
was collected, centrifuged within 30 minutes of parturition, and placed in a -80◦ C freezer for 
further analysis. Umbilical cord blood was used to determine neonatal HOMA-IR (insulin and 
glucose levels), free fatty acid concentration, and CRP.  
 
Within 48 hours of delivery, neonatal anthropometrics were measured in the CRU. Neonatal 
length (Pediatric Length Board, Ellard Instrumentation LTD, Monroe, WA) and head 
circumference (Gulick II Tape Measure, model 67020, Country Technology Inc., Gays Mills, 
WI) were measured. Body composition (fat and lean mass) was measured by skin fold thickness 
at four different sites (triceps, subscapular, ilium, and thigh, measured by one recorder) and by 
air displacement plethysmography (Pea Pod, Life Measurement, Inc., Concord, CA). All 
neonates were full-term (≥37 weeks gestation) at the time of delivery except for one in the obese 
group. For the neonate born at 36.2 weeks gestation, neonatal anthropometrics were taken when 
the neonate was 37.1 weeks gestation.  
 
2.3.3  Statistical Analysis  
Normality of the distribution for each variable was tested using Kolmogorov-Smirnov tests. 
Students Independent T-Tests for normally distributed variables and Mann-Whitney U tests for 
non-normally distributed variables were used to compare metabolic outcomes between lean and 
45 
 
obese groups. Pearson product-moment correlation coefficients for normally distributed variables 
and Spearman’s rank-order correlation coefficient for non-normally distributed variables were 
used to assess the degree of the relationship between variables. Two-way repeated-measures 
ANOVAs (group x time) were used with Tukey post hoc analyses when comparing baseline, 
exercise, and recovery conditions. Study data were collected and managed using REDCap 
electronic data capture tools hosted at Washington University School of Medicine34. All data 
analyses were conducted using IBM SPSS Statistics, Version 22 (Armonk, New York). 
 
Based on previous data comparing lipid metabolism between lean and obese females at rest and 
during exercise22, we estimated an effect size of 1.1. Therefore, with an alpha level of 0.05, 16 
women per group were required to power the study at β=0.80.  
 
2.4 Results 
 
2.4.1  Maternal Demographic Characteristics 
Obese women had significantly higher pre-pregnancy body mass indexes and body fat 
percentages than the lean group (Table 2.1). Age, parity, income level, race, and gestation age 
during study visits were similar between groups (Table 2.1). Obese pregnant women had 
significantly higher resting energy expenditure compared to lean pregnant women (Table 2.1) 
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Table 2.1 Maternal demographic and metabolic characteristics in lean and obese pregnant 
women  
 Lean (n=18) 
mean±SD 
Obese (n=16) 
mean±SD 
t-test 
p-value 
Age (y) 26.1 ± 5.0 25.0 ± 4.8 0.52 
Pre-pregnancy BMI (kg/m2)* 21.5 ± 1.9 36.3 ± 4.3 <0.001 
Body fat (%)* 20.7 ± 4.0 37.7 ± 3.5 <0.001 
Gestation age at visit 2 (wks) 35.2 ± 1.0 34.7 ± 1.4 0.25 
Gestational weight gain (kg) 14.5 ± 4.5 10.3 ±  9.2  0.12 
Heart rate (bpm) 84.1 ± 9.1 90.0 ± 10.8 0.08 
Glucose (mg/dL) 76.9 ± 5.5 80.3 ± 7.9 0.24 
Insulin (uU/mL)* 12.3 ± 8.2 18.7 ± 8.4 0.01 
HOMA-IR* 2.3 ± 1.5 3.8 ± 1.9 0.01 
C-reactive protein (mg/L)* 2.3 ± 1.8 9.1 ± 4.0 <0.001 
Total cholesterol (mg/dL) 228.4 ± 36.3 207.8 ± 35.9 0.11 
HDL (mg/dL) 67.9 ± 18.2 65.1 ± 12.3 0.61 
LDL (mg/dL) 130.2 ± 35.0 110.6 ± 34.0 0.24 
Triglycerides (mg/dL) 151.8 ± 41.8 160.0 ± 60.9 0.65 
Free fatty acids (meq/L) 0.47 ± 0.12 0.49 ± 0.15 0.64 
Resting energy expenditure 
(kcal/day)* 
1795 ± 225 2166 ± 291 <0.001 
 
 
 
# of women (%) 
 
# of women (%) 
χ²-test 
p-value 
Parity 
    Nulliparous 
    Multiparous 
 
11 (61%) 
7   (39%) 
 
10 (63%) 
6 (37%) 
 
0.93 
Income  
     Low income  
     Mod/high income  
 
10 (56%) 
8   (44%) 
 
8 (56%) 
8 (43%) 
 
0.75 
Race 
    Caucasian 
    African-American 
    Other  
 
8 (44%) 
9 (50%) 
1 (6%) 
 
5   (31%) 
10 (63%) 
1   (6%)  
 
0.73 
*p<0.05 
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2.4.2  Maternal Baseline Metabolic Characteristics 
Maternal baseline metabolic characteristics are presented in Table 2.1. Obese pregnant women 
had significantly higher plasma insulin concentration than lean pregnant women.  Obese women 
had higher HOMA-IR values compared to lean pregnant women. Maternal systolic blood 
pressure was higher in obese pregnant women compared to lean pregnant women across all time 
points (F=3.90, p=0.03). Obese pregnant women had higher plasma CRP concentrations 
compared to lean pregnant women. CRP, HOMA-IR, and systolic blood pressure data are shown 
in Figure 2.1.  
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A.                                                                                    
 
 
 
 
 
 
 
B.  
 
 
 
 
 
C.  
 
 
 
 
 
 
 
Figure 2.1 Maternal (A) inflammation (B) insulin resistance and (C) systolic blood pressure 
between lean and obese pregnant women *p<0.05 
* 
* 
*Overall p-value= 0.03 
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Dietary composition was similar between groups (Table 2.2). Three women (two lean, one 
obese) did not complete the dietary survey.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 
 
Table 2.2 Average daily dietary composition in lean and obese pregnant women  
 Lean (n=16) 
mean ± SD 
Obese (n=15) 
mean ± SD 
t-test 
p-value 
Energy intake (kcal) 2554.7 ± 1574 2058.7 ± 845 0.29 
Fat (g) 94.6 ± 50.5 69.1 ± 31.2 0.10 
Fat (% of kcal/day) 34.4 ± 5.2 30.6 ± 7.1 0.10 
Carbohydrate (g) 353.5 ± 256.2 295.4  ± 137.3 0.44 
Carbohydrates (% of kcal/day) 53.1 ± 7.2 56.9 ± 10.6 0.26 
Protein (g) 84.1  ± 39.0 73.3  ± 35.9 0.43 
Protein (% of kcal/day) 14.3 ± 3.4 14.3 ± 3.5 0.97 
*p<0.05 
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2.4.3  Maternal Lipid Metabolism 
Pregnant obese women had a higher post-exercise lipid oxidation rate compared to their lean 
counterparts (recovery: 0.11 ±0.04g/min vs. 0.13 ±0.03g/min, p=0.02) and tended to have higher 
lipid oxidation rates during baseline and exercise conditions (baseline- lean: 0.10 ± 0.04g/min vs. 
obese: 0.12 ± 0.03g/min, p=0.13; exercise- lean: 0.16 ±0.09g/min vs. obese: 0.22 ± 0.09g/min, 
p=0.09) (Figure 2.2A). Total lipid oxidation was significantly higher in the obese group (lean: 
11.8 ± 5.4g vs. obese: 15.3±4.4g, p=0.05) (Figure 2.2B). Lipolysis was similar between groups 
throughout baseline, exercise, and resting conditions.    
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A. 
 
 
 
 
 
 
 
 
 
 
B.  
 
 
 
 
 
 
 
 
 
Figure 2.2 (A) Lipid oxidation rates between lean and obese groups at baseline, during exercise, 
and during recovery from exercise (B) Total lipid oxidation measured by AUC across all 
timepoints between lean and obese pregnant women  *p<0.05 
 
* 
* p=0.13 
p=0.09 
p=0.02 
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2.4.4  Correlations between Maternal Metabolic Characteristics 
CRP was positively associated with lipid oxidation rate at baseline (r=0.42, p=0.02) (Figure 
2.3A) and during the 1-hour recovery period (r=.55, p=0.001) (Figure 2.3B). Maternal CRP was 
also related to total lipid oxidation (r=0.42, p=0.01) (Figure 2.3C).   
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A. 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
C. 
 
 
 
 
 
 
Figure 2.3 Relationships between CRP and (A) baseline lipid oxidation rate, (B) post-exercise 
recovery lipid oxidation rate, and (C) total lipid oxidation.  
r=0.42 
p=0.02 
r=0.55 
p=0.001 
r=0.40 
p=0.02 
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Similarly, baseline systolic blood pressure was positively correlated with lipid oxidation rate at 
baseline (r=0.34, p=0.05) and during the 1-hour recovery period (r=0.39, p=0.02). However, 
when accounting for CRP, the relationships between lipid oxidation rate and systolic blood 
pressure did not exist. Maternal CRP was positively correlated with maternal circulating insulin 
levels (r= 0.44, p=0.01), HOMA-IR (r=0.40, p=0.02) (Figure 2.4A), and systolic blood pressure 
(r=0.40, p=0.02) (Figure 2.4B).  Total lipid oxidation was significantly associated with lipolysis 
(r=0.57, p=0.001).  
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A.  
 
 
 
 
 
B.  
 
 
 
 
 
 
 
 
Figure 2.4 Relationships between baseline maternal inflammation and (A) insulin resistance (B) 
systolic blood pressure  
 
 
 
 
 
r=0.40 
p=0.02 
r=0.40 
p=0.02 
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2.4.5  Neonatal Anthropometric and Metabolic Outcomes  
Air displacement plethysmography was not performed on three neonates due to time of delivery 
relative to discharge, but all other neonatal anthropometrics were obtained. Cord blood could not 
be obtained from one lean and two obese participants.  Neonatal anthropometrics and metabolic 
outcomes were similar between groups (Table 2.3).   
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Table 2.3 Neonatal outcomes for neonates of lean and obese pregnant women  
Neonatal demographic 
characteristics 
Lean (n=18) 
mean ± SD 
Obese (n=16) 
mean ± SD 
t-test 
p-value  
Gestational age at delivery (wks) 39.1 ± 0.9 39.5 ± 1.4 0.33 
Birth weight (g) 3221.6 ± 377 3302 ± 447 0.57 
Length (cm) 49.5 ± 2.2 49.7 ± 2.2 0.88 
Head circumference (cm) 33.7 ± 1.7 34.3 ± 1.2 0.22 
Body fat (%) 11.1 ± 4.3 11.1 ± 3.5 0.98 
Skinfolds (cm) 
     Triceps  
     Subscapular 
     Ilium 
     Thigh 
 
4.9 ± 0.8 
4.4 ± 0.8 
4.7 ± 1.3 
6.4 ± 1.3 
 
5.1 ± 1.1 
4.4 ± 0.8 
5.0 ± 1.5 
6.8 ± 1.8 
 
0.61 
0.97 
0.56 
0.45 
 # of women (%) # of women (%) χ²-test 
p-value 
Mode of delivery 
     Vaginal 
    Cesarean 
 
14 (78%) 
4   (22%) 
 
9 (56%) 
7 (44%) 
0.27 
Gender 
     Male 
     Female  
 
7   (39%) 
11 (61%) 
 
10 (63%) 
6   (37%) 
0.30 
Neonatal cord blood values  Lean (n=17) 
mean ± SD 
Obese (n=14) 
mean ± SD 
t-test 
p-value 
Glucose (mg/dL) 88.4  ± 14.0 80.7  ± 12.8 0.13 
Insulin (uU/mL) 7.9 ± 6.2 7.5 ± 4.9 0.98 
HOMA-IR 1.7  ± 1.5 1.6  ± 1.2 0.68 
Free fatty acids (meq/L) 0.19 ± 0.08 0.16 ±0.06 0.28 
C-reactive protein (mg/L) 0.20 ± 0.10 0.24 ± 0.21 0.55 
*p<0.05 
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2.5 Discussion 
 
2.5.1  Lipid Metabolism 
Our primary novel findings from the study were: 1) maternal lipid oxidation was higher in obese 
pregnant women compared to lean pregnant women, particularly following an acute bout of low-
intensity exercise, 2) maternal lipid oxidation rate was significantly associated with maternal 
inflammation, and 3) maternal inflammation was related to maternal insulin resistance and 
systolic blood pressure. These results suggest that elevated maternal lipid oxidation might 
contribute to increased inflammation and subsequent increases in insulin resistance during late 
pregnancy in obese women. Importantly, we believe the finding of elevated lipid oxidation rates 
in obese pregnant women following a mild bout of physical activity is clinically meaningful as 
this metabolic environment would be representative of women who recently participated in 
typical daily physical activities (e.g. running errands, cleaning the house, or taking care of 
another child). Lipid oxidation rate in non-gravid adults is known to increase over resting values 
during low-to-moderate physical activity and remained effected for 2-3 hours post-exercise35,36.  
 
In the current study, higher rates of maternal lipid oxidation during rest and post-exercise 
recovery were associated with greater maternal inflammation. In non-gravid adults, lipid 
oxidation is intricately related to inflammation and insulin resistance23,37. Specifically, lipid 
oxidation by-products including reactive oxygen species have been shown to signal pathways 
that initiate an inflammatory response23,38,39. The current study also found that higher maternal 
inflammation was associated with higher insulin resistance, suggesting that maternal 
inflammation, possibly the result of increased lipid oxidation, might contribute to higher 
maternal insulin resistance in obese pregnant women. Our results are consistent with Retnakaran 
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et al. who demonstrated obesity during pregnancy elicits an inflammatory response with possible 
downstream metabolic sequela including insulin resistance40. Similarly, Korkmazer et al. found 
higher inflammation among insulin resistant pregnant women with and without a classification of 
gestational diabetes41. The clinical implications of this could be substantial as the combination of 
obesity and insulin resistance during pregnancy can lead to gestational diabetes13. Consequently, 
offspring of obese, insulin-resistant women are at increased risk for preterm delivery and its 
associated neonatal morbidity, as well as childhood metabolic dysfunction which may potentiate 
the vicious cycle of obesity and insulin resistance13. Taken together, these data suggest a 
relationship between maternal lipid metabolism, inflammation, and insulin resistance in obese 
women during pregnancy.  
 
In the current study, lipid profiles were similar between lean and obese pregnant women 
(triglycerides, total cholesterol, low-density lipoprotein, high-density lipoprotein). While 
maternal obesity is associated with increased higher plasma concentrations of triglycerides and 
low-density lipoproteins early in pregnancy42, lean and obese women reach similar 
concentrations during late pregnancy42. Our data, measured during late pregnancy, are reflective 
of the literature demonstrating similar lipid profiles between lean and obese pregnant women. 
Similarly, maternal and neonatal free fatty acid concentrations in the current study were 
consistent with Catalano et al. who reported free fatty acid concentrations in obese women and 
their fetuses were not different than lean pregnant women42,43.  
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2.5.2  Inflammation and Blood Pressure  
Although not a primary focus of the study, we also found a relationship between maternal 
inflammation and systolic blood pressure. Maternal systemic inflammation is a known feature of 
preeclampsia, a pregnancy-specific condition characterized by high blood pressure44. In fact, 
Redman et al. suggest that preeclampsia is ultimately an excessive maternal inflammatory 
response to pregnancy45. High blood pressure disorders during pregnancy, including 
preeclampsia, are an important cause of morbidity, long-term disability, and even death among 
pregnant women and their offspring46.  Inflammation has been identified as a key contributor to 
pregnancy-specific high blood pressure45,47 and our findings are consistent with this.  
 
2.5.3  Potential Role of Oxidative Stress  
Oxidative stress could provide a link connecting increased maternal lipid oxidation with 
inflammation and subsequent insulin resistance and hypertension in obese pregnant women. In 
non-gravid adults, oxidative stress is elevated in obesity48 and is associated with inflammation, 
vascular cell wall damage, high blood pressure, cardiovascular disease, poor metabolic function, 
and insulin resistance49-57. It is possible that elevated lipid oxidation rates observed in obese 
pregnant women result from inefficient and incomplete substrate oxidation; thus, potentially 
generating partially oxidized substrates (i.e. reactive oxygen species). Bell et al. concluded that 
incomplete, partial oxidation is increased in obesity58. Therefore, increased absolute lipid 
oxidation in pregnant obese women may be suggestive of increased incomplete oxidation, which 
may then be contributing to oxidative stress, and ultimately the inflammation and insulin 
resistance observed in the current study; however, this is speculative and requires further study.  
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Figure 2.5 depicts proposed pathway for the role of maternal on lipid metabolism and long-term 
maternal and neonatal outcomes.  
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Figure 2.5 Proposed pathway for maternal lipid metabolism and long-term maternal and neonatal 
outcomes  
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2.5.4  Neonatal Outcomes 
Neonates of pregnant obese woman had similar body composition, insulin resistance, and 
inflammatory markers as lean pregnant women. These results suggest that despite the metabolic 
abnormalities associated with obesity during pregnancy, the fetus may be protected from some of 
these detrimental effects, at least at 24-48 hours post-parturition. However, the “fetal origins 
hypothesis” suggests the origins of adult health diseases such as obesity, cardiovascular disease, 
and diabetes may be caused by in utero exposures59,60. Therefore, it is plausible that metabolic 
abnormalities may be epigenetically programmed, but are not apparent or measurable until later 
in life. For example, Liebowitz et al. found that offspring of obese women had higher plasma 
inflammation at 12 years of age61. Offspring of obese women with elevated plasma inflammation 
during pregnancy may develop inflammation as they age as a result of fetal programming; 
however, these changes may not be detectable at delivery when umbilical cord blood is obtained. 
Similarly, Whitaker concluded that obesity during pregnancy more than doubles the risk of 
obesity in the offspring between ages two and four62. Although neonatal body composition in our 
study was not different between lean and obese pregnant women, it is possible that differences 
might emerge during the preschool and childhood years. It is also plausible that our sample size 
was not large enough to detect a difference in birthweight or body composition as it is well-
accepted that obese women have larger babies10,11.  Based on our findings and the current 
literature, longitudinal studies of offspring born to obese women are needed.  
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2.5.5  Limitations 
A potential limitation of the present study was the observational study design, thus, cause-and-
effect relationships could not be determined from these data. Our results should be cautiously 
interpreted as this pilot study was powered based on our primary outcome of lipid oxidation rate. 
We are not adequately powered to investigate many other maternal and neonatal outcomes. Bias 
may have been introduced because measurements and assessments were not blinded (it was 
obvious who was an obese “case” versus a lean “control”), but uniform data collection 
procedures were followed for all participants to minimize bias. 
 
2.5.6  Conclusions 
We found that obese pregnant women have higher lipid oxidation rates, particularly after an 
acute bout of low-intensity exercise during late pregnancy. In addition, higher maternal lipid 
oxidation rate was associated with higher maternal inflammation. Maternal inflammation was 
related to insulin resistance and systolic blood pressure. We did not find any differences in 
neonatal metabolic outcomes between lean and obese women. Future studies investigating the 
role of maternal lipid oxidation-produced oxidative stress and interventions targeting lipid 
metabolism and inflammation to improve maternal and neonatal health in obese pregnant women 
are warranted. 
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Chapter 3: Maternal Inflammation during 
Late Pregnancy is Lower in Physically Active 
Compared to Sedentary Obese Women 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been submitted to the Journal of Applied Physiology, Nutrition, and 
Metabolism.  
Tinius RA, Cahill AG, Strand ES, Cade WT. Maternal inflammation during late pregnancy is 
lower in physically active compared to sedentary obese women. 
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3.1 Abstract 
 
Purpose: The primary purpose of this study was to compare maternal plasma inflammation 
between physically active and sedentary obese women during late pregnancy. The secondary 
purpose was to examine the relationships between maternal plasma inflammation and lipid 
metabolism and maternal and neonatal metabolic health in these women. 
Methods: A case-control study design was performed in 16 obese-sedentary ((OBS) age: 25.0 ± 
4.8 years, body fat: 37.7 ± 3.5%) and 16 obese-active ((OBA) age: 28.9 ± 4.8 years, body fat: 
36.6 ± 3.8%) women during the third trimester of pregnancy.  Maternal plasma markers of 
inflammation (C -reactive protein (CRP)) and insulin resistance (Homeostatic Model 
Assessment-Insulin Resistance (HOMA-IR)) were measured at rest. Plasma lipid concentration 
and metabolism (lipid oxidation rate and lipolysis) were measured at rest, during a 30-minute 
bout of low-intensity (40% VO2peak) exercise, and during a resting recovery period using indirect 
calorimetry. Umbilical cord blood was collected at delivery for measurement of neonatal plasma 
insulin resistance, inflammation, and lipid concentration. Neonatal body composition was 
measured 24-48 hours postpartum via air displacement plethysmography.  
Results: Maternal plasma CRP concentration was significantly higher in OBS compared to OBA 
women (9.1 ± 4.0 mg/L versus 6.3 ±2.5mg/L, p=0.02). Maternal plasma CRP concentration was 
significantly associated with maternal lipolysis (r=0.43, p=0.02), baseline lipid oxidation rate 
(r=0.39, p=0.03), and baseline plasma free fatty acid concentration (r=0.36, p=0.04).  
Conclusions: Maternal physical activity may reduce inflammation during pregnancy in obese 
women. Lipid metabolism is altered in sedentary obese women and might contribute to elevated 
systemic inflammation during pregnancy.  
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3.2 Introduction 
Maternal obesity prevalence is at a historic high with nearly one in three women entering 
pregnancy obese1. Pre-pregnancy obesity contributes to maternal inflammation, insulin 
resistance, and altered lipid metabolism2,3, as well as neonatal adiposity and insulin resistance; 
all of which can have serious long-term health implications for women and their offspring4-7. In 
particular, maternal inflammation may play a significant role in the development of maternal 
insulin resistance and hypertension- two of the most common health issues diagnosed in obese 
pregnant women8-10. Excessive maternal inflammation might also negatively contribute to 
maternal long-term health as it is predictive of future cardiovascular disease risk in non-gravid 
adults11.  
 
Physical inactivity is recognized as an independent risk factor for obesity, insulin resistance, and 
type 2 diabetes in non-gravid adults12,13. The physiological and hormonal changes associated 
with pregnancy magnify this risk during and after pregnancy by causing an increase in adiposity 
and insulin resistance14. In pregnant women of normal body weight, physical activity reduces 
inflammation15,16, as well as increases maternal insulin sensitivity17. In obese pregnant women, 
physical activity may improve maternal insulin sensitivity18.  In addition, neonates of physically 
active women have lower adiposity compared to neonates born to inactive women19,20.  
However, the role of a physically active lifestyle on maternal metabolic health, particularly 
systemic inflammation, in at-risk obese pregnant women and their neonates is poorly understood. 
To our knowledge, the impact of physical activity on maternal systemic inflammation and lipid 
metabolism, and neonatal adiposity, insulin resistance, and inflammation has not been studied in 
obese pregnant women.  
75 
 
The primary purpose of this study was to compare maternal plasma inflammation between 
physically active and sedentary obese women during pregnancy. The secondary purpose was to 
examine the relationships between maternal plasma inflammation and lipid metabolism and 
maternal and neonatal metabolic health in these women.  We hypothesized that during late 
pregnancy, physically active obese women will have lower plasma inflammation, lipid oxidation 
rate, lipolysis, and insulin resistance compared to sedentary obese women. We also hypothesized 
that neonates of physically active obese women will have lower adiposity, inflammation, and 
insulin resistance than neonates of sedentary obese women.  
 
3.3 Methods 
 
3.3.1  Participants 
Thirty-two women participated in the study (16 obese-sedentary (OBS), 16 obese-active (OBA)). 
Four-hundred women receiving prenatal care at the Women’s Health Center or Women’s Health 
Clinic at Barnes Jewish Hospital/Washington University between August 2013 and November 
2014 were screened for inclusion. Sixty women who met all criteria with ongoing pregnancies 
were approached for participation late in their second trimester. Inclusion criteria included 
women ages 18-44 years with a confirmed singleton viable pregnancy and no identified fetal 
abnormalities (as determined by routine anatomy ultrasound at 18-22 weeks) and pre-pregnancy 
BMI between 30 and 45 kg/m2. Physical activity information was gathered from health history 
questionnaires distributed by the clinic. All women in the active group reported exercising ≥150 
minutes per week. Physical activity levels were confirmed via accelerometry. Patients were 
excluded for any of the following reasons: 1) multiple gestation pregnancy,  2) inability to 
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provide voluntary informed consent, 3) self-reported use of illegal drugs (cocaine, 
methamphetamine, opiates), 4) current smoker who did not consent to cessation, 5) current usage 
of daily medications by class: corticosteroids, beta-blockers, or anti-psychotics (known to alter 
insulin resistance and metabolic profiles), 6) diagnosis of gestational diabetes in current 
pregnancy, 7) history of gestational diabetes, pre-pregnancy diabetes or prior macrosomic 
(>4500g) infant (each elevates the risk for gestational diabetes in the current pregnancy, or 
undiagnosed gestational diabetes), 8) history of heart disease, or 9) any other condition that 
would preclude exercise. Approval for this study was granted by the Institutional Review Board 
at Washington University School of Medicine (IRB ID: 201306109, NCT: NCT02039414). All 
women gave informed consent prior to participating in the study. 
 
3.3.2  Study Procedures 
All study procedures were performed at the Washington University School of Medicine Institute 
for Clinical and Translational Science’s Clinical Research Unit (CRU). All pregnant women 
participated in two maternal visits between 32 and 37 weeks of gestation.  
 
Maternal Visit 1 
Body composition was measured using skinfold anthropometry in order to determine maternal 
percent body fat. Body fat percentage was determined by pressing folds of the skin at seven sites 
with a caliper (Harpenden Skinfolds Caliper, Baty International, United Kingdom), recording 
skin fold thickness, and entering the data into a standardized equation that accounts for age as 
previously described21. Cardiorespiratory fitness levels were assessed using the YMCA 
submaximal multistage cycle ergometer test as described by Beekley et al. (2004) using a Lode 
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Corvial Recumbent cycle ergometer (Lode B.V., The Netherlands). Results were used to predict 
participant’s VO2peak via the VO2-Heart Rate extraction method, which is considered more 
accurate for pregnant women than the Astrand-Ryhming test22. A three-lead electrocardiogram 
was applied to monitor heart rate during the exercise test.  Participants also completed the 
National Institutes of Health’s validated Dietary History Questionnaire II to determine potential 
differences in diet23.   
 
Maternal physical activity levels were objectively assessed during the week following visit one 
using the ActiGraph GT3X+ accelerometer (ActiGraph LLC, Pensacola, FL). The GTX3+ was 
placed on the non-dominant wrist with non-removable wristbands. The wristbands were cut off 
by the study team when they returned for their second visit to ensure the accelerometers were 
worn for the entire data collection period. Data was collected for seven consecutive days at 30 
Hz. The accelerometer output was sampled by a 12-bit analog-to-digital converter. The 
percentage of time spent sedentary as well as the amount of time spent participating in different 
categories of physical activity ranging from light and lifestyle to moderate were calculated using 
algorithms corresponding to the following activity counts: sedentary: 0 - 99 counts/min, light: 
100 - 759 counts/min, lifestyle: 760 - 1951 counts/min, moderate: 1952-5724  counts/min24,25.   
 
Maternal Visit 2 
Approximately one week after Visit 1, participants were admitted to the CRU the morning after 
an overnight fast. The night prior, subjects were provided with written instructions from the 
research unit dietician for consuming a balanced meal with approximately 50% carbohydrate, 
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30% fat, and 20% protein. Upon admission to the CRU, height, weight, and vital signs were 
obtained. A catheter (IV) was placed in a hand vein and heated to 55 °C by using a 
thermostatically controlled box in order to obtain arterialized blood samples as previously 
described26. Participants kept their hand in the box throughout the entire study visit. Participants 
laid supine for 30 minutes and rested quietly prior to a baseline 15-minute resting indirect 
calorimetry measurement using the TrueOne Canopy Option and TrueOne Metabolic Cart 
(TrueOne 2400, Parvomedics, Sandy, UT). Lipid oxidation rate was calculated by measurement 
of oxygen consumption and carbon dioxide production as previously described27. After a 
baseline blood draw, participants exercised at approximately 40% of their predicted VO2peak  
(based on the YMCA submaximal cycle test) for 30 minutes. Blood was drawn at 10, 20, and 30 
minute time points during submaximal exercise. Indirect calorimetry was also performed at 10, 
20, and 30 minutes (for 2 minutes at a time) during submaximal exercise using an exercise 
mouthpiece and nose clip for calculation of lipid oxidation rate during low-intensity exercise. 
Lipid metabolism was examined during exercise because exercise upregulates adipose tissue 
breakdown (lipolysis) and lipid oxidation28. In addition, we believe the exercise paradigm 
mimicked daily activity levels (~3-5 METS, e.g. household chores, caring for other children, 
walking), thus, representing metabolism during and after normal daily activities. After exercise 
termination, participants returned to supine and blood was drawn 10, 30, and 60 minutes-post 
cessation of exercise (i.e. recovery). Resting indirect calorimetry using the canopy option was 
performed a second time for 15 minutes midway through the post-exercise recovery period. Visit 
2 study procedures are shown in Figure 3.1. 
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Figure 3.1 Summary of visit 2 procedures 
 
 
 
 
 
 
 
 
 
 
80 
 
Sample Analyses and Calculations 
All blood samples were immediately placed on ice and plasma was separated by centrifugation 
within 30 minutes of collection. Plasma samples were stored at -80ºC until final analyses were 
performed. Blood samples for glucose were collected in heparinized tubes and analyzed 
immediately with an automated glucose analyzer (Yellow Springs Instruments Co, Yellow 
Springs, OH). Plasma insulin concentration was measured by electrochemiluminescence 
technology (Elecsys 2010, Roche Diagnostics, Indianapolis, IN). Insulin and glucose levels were 
used to calculate the homeostatic model assessment-insulin resistance (HOMA-IR)29,30. The 
HOMA-IR is an index of insulin resistance that reflects fasting glucose concentration measured 
at the fasting insulin concentration. High-sensitivity C-reactive protein (CRP) was measured by 
immunoturbidimetric assay (Roach Diagnostics, Indianapolis, IN). Blood samples used to 
determine plasma free fatty acids were collected in tubes containing EDTA. Plasma free fatty 
acid concentrations were determined by enzymatic colorimetric assay (Wako Pure Chemical 
Industries, Osaka, Japan). Lipolysis was calculated by the area under the curve for free fatty 
acids as previously described 31 from free fatty acid concentrations from baseline and throughout 
the exercise and recovery periods.  
 
Neonatal Measurements 
 Upon admission to labor and delivery, maternal weight was measured and gestational weight 
gain was calculated. At parturition, neonatal birth weight was obtained. In addition, 44 mL of 
umbilical cord blood was collected, centrifuged within 30 minutes of delivery, and stored at         
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-80ºC until further analyses were performed. Umbilical cord blood was used to determine 
neonatal HOMA-IR, free fatty acid concentration, and inflammation (CRP).  
 
Within 48 hours of delivery, neonatal anthropometrics were measured in the CRU. Neonatal 
length (Pediatric Length Board, Ellard Instrumentation LTD, Monroe, WA) and head 
circumference (Gulick II Tape Measure, model 67020, Country Technology Inc., Gays Mills,  
WI) were measured. Body composition (fat and lean mass) was measured by skin fold thickness 
 (Harpenden calipers, Baty International, West Sussex, UK) at four different sites (triceps, 
subscapular, ilium, and thigh) and by air displacement plethysmography (Pea Pod, Life 
Measurement, Inc., Concord, CA). All neonates were full-term (≥37 weeks) at the time of 
delivery except for one in the OBS group. For the neonate born at 36.2 weeks gestation, neonatal 
anthropometrics were taken when the neonate was 37.1 weeks gestation. 
 
3.3.3  Statistical Analysis 
The study was primarily powered based on CRP data in sedentary obese pregnant women from 
Sen et al.32 who demonstrated that sedentary obese women had CRP levels over twice as high as 
lean pregnant women (no studies have compared plasma CRP levels between physically active 
and inactive obese pregnant women).  Using a two-tailed alpha of 0.05, 30 total participants (15 
per group) were needed to adequately power our study at 0.85 (beta=0.15). One neonate in the 
OBA group was lost to follow-up, thus, an extra participant was recruited to ensure adequate 
power.  
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Normality of the distribution for each variable was tested using Kolmogorov-Smirnov tests. 
Student’s Independent T-Tests for normally distributed variables and Mann-Whitney U tests for 
non-normally distributed variables were used to compare metabolic outcomes between OBA and 
OBS women. Two-way repeated-measures ANOVAs (group x time) were used with Tukey post 
hoc analyses when comparing baseline, exercise, and recovery conditions.  Covariates were used 
to statistically account for differences in age, race, parity, income, and dietary composition 
between groups when necessary. Pearson product-moment correlation coefficients for normally 
distributed variables or Spearman’s rank-order correlation coefficient for non-normally 
distributed variables were used to assess the degree of the relationships between variables. Partial 
correlations were used to adjust for potential confounders. All tests were two-sided with a p-
value <0.05 denoting statistical significance. Data were collected and managed using Research 
Electronic Data Capture (REDCap), hosted at Washington University School of Medicine33. All 
data analyses were conducted using IBM SPSS Statistics, Version 22 (Armonk, New York).  
 
3.4  Results 
 
3.4.1  Maternal Demographic Characteristics 
OBA women were older than OBS women, but all other demographics were similar between the 
groups (Table 3.1).  
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Table 3.1 Maternal demographic and metabolic characteristics in OBS and OBA pregnant 
women 
 OBS (n=16) 
mean±SD 
OBA  (n=16) 
mean±SD 
t-test 
p-value 
Age (y)* 25.0 ± 4.8 28.9 ± 4.8 0.03 
Pre-pregnancy BMI (kg/m2) 36.3 ± 4.3 34.0 ± 3.7 0.09 
Body fat (%) 37.7 ± 3.5 36.6 ± 3.8 0.43 
Gestation age at visit 2 (wks) 34.7 ± 1.4 34.4 ± 1.3 0.58 
Gestational weight gain (kg) 10.3 ± 9.2 9.5 ± 6.8 0.78 
Heart rate (bpm) 90.0 ± 10.8 88.5 ± 12.3 0.73 
Systolic blood pressure (mmHg) 112.0 ± 10.9 111.6 ± 8.8 0.96 
Diastolic blood pressure (mmHg) 71.5 ± 4.3 69.3 ± 7.9 0.33 
Glucose (mg/dL) 80.3 ± 7.9 80.2 ± 8.3 0.96 
Insulin (uU/mL) 18.7 ± 8.4 15.6 ± 9.1 0.24 
HOMA-IR 3.8 ± 1.9 3.2 ± 2.3 0.24 
C-reactive protein (mg/L)* 9.1 ± 4.0 6.3 ± 2.5 0.02 
Total cholesterol (mg/dL) 207.8 ± 35.9 212.6 ± 46.1 0.74 
HDL (mg/dL) 65.1 ± 12.3 68.5 ± 14.1 0.47 
LDL (mg/dL) 110.6 ± 34.0 112.9 ± 39.9 0.87 
Triglycerides (mg/dL) 160.0 ± 60.9 155.9 ± 59.9 0.85 
Free fatty acids (meq/L) 0.49 ± 0.15 0.45 ± 0.14 0.46 
Lipolysis (meq∙min/L)* 42.1 ± 11.0 36.9 ± 7.2 0.03 
Resting energy expenditure (kcal/day) 2167 ± 291 2099 ± 338 0.55 
 
 # of women (%) # of women (%) 
χ²-test 
p-value 
Parity 
    Nulliparous 
    Multiparous 
 
10 (63%) 
 6 (37%) 
 
7 (44%) 
9 (56%) 
0.29 
Income  
     Low income  
     Mod/high income  
 
8 (50%) 
8 (50%) 
 
5 (31%) 
11 (69%) 
0.28 
Race 
    Caucasian 
    African-American 
    Other  
 
5 (31%) 
10 (63%) 
1 (6%)  
 
9 (56%) 
6 (38%) 
1 (6%)  
0.34 
*p<0.05 
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Dietary composition was similar between groups; however, there was a trend for OBA women to 
consume a higher percentage of dietary fats (Table 3.2). Dietary fats were used as a covariate in 
subsequent analysis involving lipid metabolism because dietary fat consumption can 
significantly influence lipid metabolism34.   
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Table 3.2 Average daily dietary composition in OBS and OBA pregnant women 
 OBS (n=15) 
mean±SD 
OBA (n=16) 
mean±SD 
t-test  
p-value  
Energy intake (kcal) 2058.7 ± 845 2369.0 ± 1252 0.43 
Fat (g) 69.1 ± 31.2 94.0 ± 62.9 0.18 
Fat (% of kcal/day) 30.6  ± 7.1 34.9  ± 5.0 0.06 
Carbohydrate (g) 295.4  ± 137 295.0  ± 122 0.99 
Carbohydrate (% of kcal/day) 56.9 ± 10.6 51.4 ± 7.9 0.11 
Protein (g) 73.3  ± 35.9 98.5  ± 68.1 0.21 
Protein (% of kcal/day) 14.3  ± 3.5 16.1  ± 3.2 0.15 
*p<0.05 
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OBA women spent significantly less time sedentary (72.3 ± 4.3% vs. 58.4 ± 5.9%, p<0.001), and 
more time in light (9.5 ± 1.7% vs. 7.6 ± 0.9%, p=0.001), lifestyle (15.2 ± 2.2% vs.10.4 ± 0.8%, 
p<0.001), and moderate (16.9 ± 4.4% vs. 9.7 ± 2.2% vs., p<0.001) physical activities than the 
OBS women (Figure 3.2).  
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Figure 3.2 Time spent sedentary and participating in light, lifestyle, and moderate physical 
activities in OBS and OBA pregnant women *p<0.05 
 
 
 
 
 
p<0.001 
p=0.001 p<0.001 p<0.001 
* 
* 
* 
* 
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OBA women also had higher predicted fitness levels compared to OBS women (33.7± 6.4 
ml/kg/min vs. 24.7± 3.5 ml/kg/min, p<0.001). All OBA reported their primary mode of activity 
being walking (n=16), while reported secondary activities were biking (n=1), swimming (n=1), 
yoga (n=2), weight-lifting (n=2), and using the elliptical machine (n=2).  
 
3.4.2  Maternal Metabolic Characteristics 
Maternal plasma CRP concentration was significantly lower in OBA women compared to OBS 
women (6.3 ± 2.5 mg/L versus 9.1 ± 4.0 mg/L, p=0.02) (Figure 3.3). When adjusting for 
differences in age, race, parity, and income between groups, CRP remained significantly lower in 
OBA women compared to OBS women (p=0.002).  
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Figure 3.3 Maternal CRP in OBS and OBA pregnant women *p<0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 * 
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OBA women had a lower lipolysis (36.9 ± 7.2 meq∙min/L vs. 42.1 ± 11.0 meq∙min/L, p=0.03) 
(Figure 3.4A) and tended to have lower circulating free fatty acids (F= 3.04, p=0.09), particularly 
during the exercise bout (30 minute time point) (0.36 ± 0.10 meq/L vs. 0.42 ± 0.13 meq/L, 
p=0.03) (Figure 3.4B) compared to OBS women. There were no differences in lipid oxidation 
rates between groups (Figure 3.4C).  
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A.  
 
 
 
B.  
 
 
 
 
C. 
 
 
 
 
 
Figure 3.4  (A) Maternal lipolysis (B) Maternal plasma circulating free fatty acids during 
baseline, exercise, and recovery conditions (C) Maternal lipid oxidation rates in OBS and OBA 
women during baseline, exercise, and recovery conditions *p<0.05 
 
* 
  * 
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Maternal lipolysis was significantly correlated to maternal plasma CRP concentration (r=0.43, 
p=0.02). Maternal baseline free fatty concentration was also correlated to maternal plasma CRP 
concentration (r=0.36, p=0.04). Similarly, maternal baseline lipid oxidation rate and maternal 
plasma CRP concentration were positively correlated (r=0.39, p=0.03).When the relationship 
between lipid oxidation and inflammation was analyzed in the OBA and OBS groups 
individually, lipid oxidation and CRP had a moderate positive correlation in OBS women 
(r=0.50 p=0.06), but not in OBA women (r= -0.12, p=0.67) (Figure 3.5).  
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Figure 3.5 Relationship between maternal lipid oxidation rate and maternal CRP in OBS and 
OBA women  
 
 
 
 
 
 
 
r=0.50, p=0.06 
r=-0.12, p=0.67 
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3.4.3  Neonatal Outcomes 
Neonatal anthropometrics were not obtained for one neonate who was lost to follow-up. Cord 
blood could not be obtained for two OBS and four OBA women/neonates. Neonatal 
anthropometric and metabolic outcomes were similar between groups (Table 3.3).  
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Table 3.3 Neonatal outcomes for neonates of OBS and OBA pregnant women 
 
Anthropometric outcomes 
OBS (n= 16) 
mean±SD 
OBA (n=15) 
mean±SD 
t-test 
p-value 
Gestational age at delivery (wks) 39.5 ± 1.4 39.0  ± 1.3 0.25 
Birth weight (g) 3302 ± 447 3299.9 ± 515 0.99 
Length (cm) 49.7 ± 2.2 49.6 ± 2.3 0.99 
Head circumference (cm) 34.3 ± 1.2 34.3 ± 1.3 0.92 
Body fat (%) 11.1 ± 3.5 12.4 ± 2.9 0.29 
Skinfolds 
     Triceps  
     Subscapular 
     Ilium 
     Thigh 
 
5.1 ± 1.1 
4.4 ± 0.8 
5.0 ± 1.5 
6.8 ± 1.8 
 
4.7 ± 0.9 
4.3 ± 0.6 
4.7 ± 1.2 
6.4 ± 1.3 
 
0.32 
0.83 
0.54 
0.50 
 # of neonates (%) # of neonates (%) χ²-test 
p-value 
Mode of delivery  
     Vaginal 
     Cesarean  
 
9 (56%) 
7 (44%) 
 
11 (69%) 
5   (31%) 
0.72 
Gender 
    Male 
    Female 
 
10 (63%) 
6   (37%) 
 
9 (56%) 
7 (44%) 
0.72 
Cord blood values (n=14) 
mean±SD 
(n=12) 
mean±SD 
t-test  
p-value 
Glucose (mg/dL) 80.7  ± 12.8 88.3 ± 20.7 0.31 
Insulin (uU/mL) 7.5 ± 4.9 9.0 ± 7.2 0.57 
HOMA-IR 1.6  ± 1.2 1.9 ± 1.6 0.55 
Free fatty acids (meq/L) 0.16 ±0.06 0.16 ± 0.07 0.89 
C-reactive protein (mg/L) 0.24 ± 0.21 0.16 ± 0.14 0.32 
*p<0.05 
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There were no significant relationships between maternal and neonatal adiposity (r= -0.25, 
p=0.18), maternal and neonatal inflammation (r=0.19, p=0.37), or maternal and neonatal insulin 
resistance (r=0.20, p=0.35).  
 
3.5 Discussion 
 
3.5.1  Maternal Outcomes 
The primary finding of this study was that during late pregnancy, maternal systemic 
inflammation, measured by C-reactive protein, was lower in physically active obese women 
compared to sedentary obese women during late pregnancy. Our finding is consistent with 
Hawkins et al. who found that physical activity has a protective effect on CRP in normal-weight 
pregnant women during the second trimester35. Our study extends this work by demonstrating the 
benefits of physical activity on inflammation also apply to obese pregnant women during late 
pregnancy- a population at high risk for excessive inflammation and its downstream sequela. 
This finding may be clinically significant as higher inflammation might contribute to the 
increased acute and chronic risk for the development of metabolic complications (e.g. insulin 
resistance, gestational diabetes, hypertension, metabolic syndrome, cardiovascular disease)8,36,37 
as well as additional risks for maternal infection, preterm delivery, and severe preeclampsia9.  
Additionally, higher inflammation in sedentary obese women during pregnancy will likely 
persist into postpartum38; thus, potentially contributing to a higher long-term diabetes and 
cardiovascular disease risk11.  
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In non-gravid obese adults, excessive plasma free fatty acids and lipid oxidation are believed to 
initiate an inflammatory response39. In the current study, maternal lipid oxidation and lipolysis 
were associated with maternal inflammation, suggesting that this relationship between lipid 
metabolism and inflammation also exists in obese pregnant women. We suspect maternal 
physical activity during pregnancy might modulate lipid metabolism as obese active women had 
lower plasma free fatty acid concentrations and lower lipolysis. Our findings are consistent with 
data in non-gravid adults that suggests endurance exercise training increases efficiency of lipid 
metabolism including decreasing plasma free fatty acid turnover and oxidation during 
submaximal exercise40.  Our study suggests maternal lipid metabolism might be moderately 
improved in obese women who participate in physical activity, and that this improvement may 
contribute to lower inflammation. Our finding is clinically important as lipid metabolism may be 
a modifiable upstream target that contributes to systemic inflammation in obese pregnant 
women.  
 
Another possible mechanism for physical activity-associated improvements in maternal 
inflammation in obese pregnant women is through a reduction in oxidative stress. Inflammation 
is believed to be a manifestation of oxidative stress, which is increased in obese individuals41. 
Studies have demonstrated that exercise training upregulates antioxidant capacity, thus 
decreasing oxidative stress42. In our cohort of obese pregnant women, it is plausible that regular 
physical activity improved their antioxidant capacity which decreased their oxidative stress, and 
this lead to a subsequent decrease in inflammation. Further support of this theory is the 
connection between lipid metabolism and oxidative stress; oxidative stress is a known by-
product of inefficient lipid metabolism43. Therefore, the lower lipolysis and free fatty acid 
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concentration found in obese active women may be contributing to a reduction in oxidative 
stress, and thus, a reduction in systemic inflammation. However, oxidative stress and antioxidant 
capacity were not measured in the current study; therefore, the role of oxidative stress is 
speculative. 
 
Upon further examination, we noted that the relationship between lipid oxidation and 
inflammation was primarily driven by the obese sedentary group. Lipid oxidation and 
inflammation were positively correlated in obese sedentary women, but this relationship did not 
exist in the obese active group.  This suggests that although lipid oxidation rates were not 
different between obese sedentary and obese active groups, the positive correlation between lipid 
oxidation and inflammation in obese sedentary pregnant women may be due to inefficient and 
incomplete lipid oxidation. Incomplete lipid oxidation may then be contributing to downstream 
inflammation, which is supported by the increased C-reactive protein in the obese sedentary 
group. Bell et al. suggests that in obesity, lipid oxidation may be incomplete and inefficient, 
leading to oxidative stress39,43- a known contributor to inflammation41. It is well-established that 
exercise improves efficiency of lipid metabolism as well as reduces oxidative stress40,44. 
Therefore, it is plausible that the reason for the lack-of association between lipid oxidation and 
inflammation in the obese active group was due to obese active women having improved 
efficiency of lipid metabolism resulting in complete oxidation of lipids, lower oxidative stress, 
and lower systemic inflammation. Unfortunately, intermediate by-products of lipid metabolism 
were not measured, and we did not assess whether or not lipid oxidation was complete; therefore, 
this is speculative. 
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3.5.2  Neonatal Outcomes  
Contrary to our hypothesis, there were no differences in neonatal metabolic outcomes between 
obese sedentary and obese active women. Our study suggests that although neonates of obese 
active women were not leaner, exercise during pregnancy in this at-risk population does not 
appear to have a harmful impact on neonatal birth weight. These data are clinically important as 
the neonatal risks associated with obese pregnant women participating in exercise regimes are 
largely unknown.  
 
Maternal inflammation and insulin resistance were not related to any neonatal metabolic 
outcomes (adiposity, insulin resistance, or inflammation). These findings suggest that maternal 
metabolic health may not have an acute impact on neonatal metabolic health. However, 
metabolic abnormalities may be programmed but not apparent or measurable until later in life45. 
One of the primary ideas behind the “fetal origins hypothesis” is the programming of poor 
metabolic health can remain latent for many years in the offspring45,46.  Several studies have 
noted a long-term impact of maternal obesity or physical activity on neonatal adiposity and 
inflammation47,48.  Thus, long-term follow-up of neonates born to obese sedentary and obese 
active women are needed to truly determine the impact of physical activity on long-term 
offspring health in obese pregnant women.  
 
3.5.3  Conclusions 
We found that inflammation is lower in physically active obese pregnant women when compared 
to sedentary obese pregnant women. The reduction in inflammation among physically active 
obese women might be related to improvements in lipid metabolism as measures of lipid 
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metabolism and inflammation were related. Maternal physical activity did not influence neonatal 
metabolic outcomes, but long-term follow-up is needed.  
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Chapter 4: Relationships between Late 
Pregnancy Maternal and Neonatal Metabolic 
Health in Lean and Obese Women 
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4.1 Abstract 
 
Introduction: The purpose of this study was to examine the relationships between maternal and 
neonatal metabolic health in lean and obese women during late pregnancy. 
Methods: Fifty women participated in this study between 32-37 weeks gestation (N=50).  
Maternal indices of insulin resistance (homeostatic model assessment-insulin resistance 
(HOMA-IR)) and inflammation (C - reactive protein (CRP)), as well as lipid concentration and 
kinetics (lipid oxidation rate and lipolysis) were measured under basal conditions. Umbilical 
cord blood was collected at parturition for measurement of neonatal plasma insulin resistance, 
inflammation, and lipid concentration. Neonatal body composition was measured 24-48 hours 
postpartum via air displacement plethysmography.  
Results: There were no significant relationships between maternal and neonatal metabolic 
outcomes in a cohort of lean and obese pregnant women. In lean pregnant women, maternal pre-
pregnancy BMI was positively associated with neonatal body fat percentage (r=0.65, p=0.01). 
However, in obese pregnant women, maternal pre-pregnancy BMI trended towards a negative 
correlation with neonatal body fat percentage (r=-0.34, p=0.06). In the neonates, there was a 
trend for neonatal HOMA-IR to be positively correlated with neonatal body fat percentage 
(r=0.30, p=0.07).  
Conclusions: We found no associations between maternal lipid metabolism, insulin resistance, 
and inflammation and neonatal adiposity, insulin resistance, and inflammation in a cohort of lean 
and obese pregnant women. 
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4.2 Introduction 
The “fetal origins hypothesis” suggests that the origins of adult chronic health conditions (e.g. 
diabetes, cardiovascular disease) are initiated by in utero exposures1.  This hypothesis states that 
unfavorable metabolic health may “program” the fetus to have metabolic characteristics that can 
lead to future disease2-5. Metabolic characteristics associated with future cardiovascular disease 
include (but are not limited to) altered lipid profiles, inflammation, insulin resistance, and 
obesity6-10. Alterations in maternal metabolism may play a crucial role in adverse fetal 
programming, leading to unfavorable maternal and neonatal outcomes with long-term health 
implications11-13.  
 
A careful understanding of maternal lipid and glucose metabolism, and their relationships to 
neonatal health, is critical as both are believed to play an important role in fetal development and 
maternal and neonatal metabolic health14-17. Lipid metabolism may contribute to maternal health 
during pregnancy as it is intricately connected to inflammation and insulin resistance in non-
gravid adults18,19.  Maternal inflammation and insulin resistance during pregnancy can have 
serious implications for pregnant women and their neonates14,20,21.  In addition, maternal lipid 
and glucose metabolism have been linked with changes in neonatal body composition and 
birthweight7,22-24. Despite the connections between maternal metabolism and neonatal body 
composition, few studies have examined the direct relationships between maternal metabolism 
(i.e. lipid metabolism, insulin resistance, and inflammation) and neonatal metabolic outcomes 
including adiposity, inflammation, and insulin resistance.  The purpose of this study was to 
examine the relationships between late pregnancy maternal and neonatal metabolic health in lean 
and obese women. We hypothesize that higher maternal lipid oxidation rate and lipolysis will be 
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associated with higher adiposity, inflammation, and insulin resistance in neonates.  We also 
believe maternal and neonatal inflammation and insulin resistance will be positively correlated. 
Establishing relationships between maternal and neonatal metabolic characteristics might aid the 
development of interventions that modulate the maternal metabolic environment that contributes 
to adverse outcomes and fetal programming during pregnancy.   
4.3 Methods 
 
4.3.1  Participants 
Fifty (n=50) women participated in the study between 32 and 37 weeks gestation.  Of these 50 
women, 16 were lean (18.5≤ BMI< 25.0 kg/m2) and 32 were obese (30kg/m2≤ BMI <45kg/m2). 
Five-hundred women receiving prenatal care at the Women’s Health Center at Barnes Jewish 
Hospital/Washington University were screened for inclusion. Women who met all criteria with 
ongoing pregnancies were approached for participation late in their second trimester.  Inclusion 
criteria were ages 18-44, confirmed singleton viable pregnancy with no identified fetal 
abnormalities (as determined by routine standard of care ultrasonography at 18-22 weeks), and 
pre-pregnancy BMI between 18.5 and 24.9 (lean) or 30 and 45 kg/m2 (obese). Exclusions 
included: 1) multiple gestation pregnancy, 2) inability to provide voluntary informed consent,  3) 
self-reported use of illegal drugs (cocaine, methamphetamine, opiates),  4) current smoker who 
does not consent to cessation, 5) current usage of daily medications by class: corticosteroids, 
anti-psychotics (known to alter insulin resistance and metabolic profiles), 6) diagnosis of 
gestational diabetes in current pregnancy, history of gestational diabetes, pre-pregnancy diabetes 
or prior macrosomic (>4500g) infant (which elevate the risk for gestational diabetes in the 
current pregnancy, or undiagnosed gestational diabetes), or 7) history of heart disease.   
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4.3.2  Study Procedures  
All study procedures were performed during two visits at the Washington University School of 
Medicine Institute for Clinical and Translational Sciences Clinical Research Unit (CRU).  
 
Maternal Visit 1 
Maternal body composition was measured using skinfold anthropometry. Body fat percentage 
was determined by pressing folds of the skin at seven sites with a caliper (Harpenden Skinfolds 
Caliper, Baty International, United Kingdom), recording the skin fold thickness, and entering the 
data into a standardized equation that accounts for age as previously described25. In order to 
account for variables that may distort the relationships between maternal and neonatal outcomes, 
maternal fitness and physical activity levels, and maternal dietary composition were measured. 
Maternal fitness levels were assessed using the YMCA submaximal cycle test on a recumbent 
bicycle (Lode Corvial Recumbent, Lode B.V., The Netherlands)26.  Maternal physical activity 
levels were objectively assessed for one week using the ActiGraph GT3X+ accelerometer 
(ActiGraph LLC, Pensacola, FL). The GTX3+ was placed on the non-dominant wrist for seven 
consecutive days. Data was collected at 30 Hz and the output was sampled by a twelve-bit 
analog-to-digital-converter. The percentage of time spent sedentary as well as percentage of time 
spent in different levels of physical activity ranging from light and lifestyle to moderate, were 
calculated using algorithms and cut points from Freedson et al. in the ActiGraph software27. In 
order to assess dietary composition, participants completed the validated National Institutes of 
Health’s Dietary History Questionnaire II28. Previous literature demonstrates that dietary history 
questionnaires are valid and reproducible among pregnant populations29.  
 
Maternal Visit 2 
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Subjects were admitted to the CRU the morning after an overnight fast. The night prior, subjects 
were provided written instructions for consuming a balanced meal with 50% carbohydrate, 30% 
fat, and 20% protein. Upon admission to the CRU, height, weight, and vital signs were obtained. 
A catheter (IV) was placed in a hand vein and heated to 55 °C by using a thermostatically 
controlled box in order to obtain arterialized blood samples. Participants laid supine for 30 
minutes prior to a 15-minute resting indirect calorimetry measurement (TrueOne 2400, 
Parvomedics, Sandy, UT). Lipid oxidation rate was calculated via oxygen consumption and 
carbon dioxide production as previously described30.  
 
Sample Analyses and Calculations 
All blood samples were immediately placed on ice and plasma was separated by centrifugation 
within 30 minutes of collection. Plasma samples were stored at -80ºC until final analyses were 
performed. Blood samples for glucose were collected in heparinized tubes and analyzed 
immediately with an automated glucose analyzer (Yellow Springs Instruments Co, Yellow 
Springs, OH). Plasma insulin concentration was measured by electrochemiluminescence 
technology (Elecsys 2010, Roche Diagnostics, Indianapolis, IN). Insulin and glucose levels were 
used to calculate the  homeostatic model assessment-insulin resistance (HOMA-IR)31,32. The 
HOMA-IR is an index of insulin resistance that reflects fasting glucose concentration measured 
at the fasting insulin concentration. High-sensitivity C-reactive protein (CRP) was measured by 
immunoturbidimetric assay (Roach Diagnostics, Indianapolis, IN). Blood samples used to 
determine plasma free fatty acids were collected in tubes containing EDTA. Plasma free fatty 
acid concentrations were determined by enzymatic colorimetric assay (Wako Pure Chemical 
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Industries, Osaka, Japan). Lipolysis was calculated by the area under the curve for free fatty 
acids as previously reported33 from baseline through exercise and the recovery period.  
 
Neonatal Measurements 
 Upon admission to labor and delivery, maternal weight was measured and gestational weight 
gain was determined. At parturition, neonatal birth weight was obtained. In addition, 44 mL of 
umbilical cord blood was collected, centrifuged within 30 minutes of parturition, and placed at 
 -80ºC until further analysis was performed. Umbilical cord blood was used to determine 
neonatal HOMA-IR (insulin and glucose levels), free fatty acid concentration, and inflammation 
(CRP).   
 
Within 48 hours of delivery, neonatal anthropometrics were measured in the CRU. Neonatal 
length (Pediatric Length Board, Ellard Instrumentation LTD, Monroe, WA) and head 
circumference (Gulick II Tape Measure, model 67020, Country Technology Inc., Gays Mills, 
WI) were measured. Body composition (fat and lean mass) was measured by skin fold thickness 
measurement at four different sites (triceps, subscapular, ilium, and thigh) and by air 
displacement plethysmography (Pea Pod, Life Measurement, Inc., Concord, CA). All 
anthropometric measurements were taken on full-term neonates (≥37 weeks gestation).  
 
4.3.3  Statistical Analysis 
Normality of the distribution was tested for each variable using Kolmogorov-Smirnov tests. 
Pearson Product-Moment Correlation Coefficients for normally distributed variables and 
Spearman’s Rank-Order Correlation Coefficients for non-normally distributed variables were 
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used to assess the degree of the relationship between variables. In order to assess the impact of 
discrete variables such as race, parity, and income on neonatal outcomes and account for 
potential confounding, Student’s Independent T-Tests for normally distributed variables and 
Mann-Whitney U Tests on non-normally distributed data were performed.  Partial correlations 
were used to adjust for potential confounders.  Relationships were also analyzed within each 
group (lean and obese) in order to determine how pre-pregnancy BMI may impact mechanisms 
linking maternal and neonatal health. Study data were collected and managed using Research 
Electronic Data Capture (REDCap) electronic data capture tools hosted at Washington 
University School of Medicine34. All data analyses were conducted using IBM SPSS Statistics, 
Version 22 (Armonk, New York) 
 
4.4 Results 
 
4.4.1  Maternal Outcomes 
Maternal demographic characteristics are shown in Table 4.1.  
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Table 4.1 Maternal demographic characteristics in lean and obese pregnant women 
 All (N=50) 
mean ± SD 
Lean (n=18) 
mean ± SD 
Obese (n=32) 
mean ± SD 
Age (y) 26.6 ± 5.0 26.1 ± 5.0 26.9 ± 5.1 
Pre-pregnancy BMI (kg/m2) 30.2  ± 7.5 21.5 ± 1.9 35.2 ± 4.1 
Body fat (%) 31.2 ± 8.8 20.7 ± 4.0 37.1 ± 3.7 
Resting systolic blood pressure 
(mmHg) 
110.2 ± 9.4 107.3 ± 8.1 111.8 ±9.8 
Resting diastolic blood pressure 
(mmHg) 
70.0 ± 6.8 69.3 ± 7.6 70.4 ± 6.4 
Resting heart rate (bpm) 87.4 ± 10.8 84.1 ± 9.1 89.3 ± 11.4 
Gestational weight gain (kg) 11.8 ± 7.1 14.5 ± 4.5 10.3 ± 7.9 
 # of women 
(%) 
# of women 
(%) 
# of women 
(%) 
Race 
     African-American 
     Caucasian 
     Other 
 
26 (52%) 
21 (42%) 
 3  ( 6%) 
 
8 (44%) 
9 (50%) 
1 (6%) 
 
14 (44%) 
16 (50%) 
2   (6%) 
Parity 
     Nulliparous 
    Multiparous 
 
28 (56%) 
22 (44%) 
 
11 (61%) 
7   (39%) 
 
17 (53%) 
15 (47%) 
Income  
     Low 
     Moderate-to-high 
 
23 (46%) 
27 (54%) 
 
10 (56%) 
8   (44%) 
 
13 (41%) 
19 (59%) 
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Demographic characteristics, aside from BMI and body fat percentage, were similar between 
lean and obese women. Neonatal outcomes were similar between women of difference races, as 
well as multiparous versus nulliparous women. Neonatal CRP was significantly lower in women 
with moderate-to-high-income versus women with low-income (moderate-to-high-income: 0.16 
± 0.12 mg/L vs. low-income: 0.26 ± 0.19 mg/L, p=0.02). Maternal dietary composition and 
physical activity levels were similar between groups and were not related to any neonatal 
outcomes. Table 4.2 shows maternal dietary composition and physical activity levels. 
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Table 4.2 Maternal dietary composition and physical activity levels in lean and obese pregnant 
women  
Daily dietary consumption  All (N=50) 
mean ± SD 
Lean (n=18) 
mean ± SD 
Obese (n=32) 
mean ± SD 
     Total energy (kcal) 2333 ± 1257 2554 ± 1574 2218 ± 1068 
     Fat (g) 86.3 ± 50.6 94.6 ± 50.5 81.9 ± 51.0 
    Fat (% of kcal/day) 33.4 ± 6.0 34.4 ± 5.2 32.8 ± 6.4 
    Carbohydrates (g) 315.0 ± 181.0 353.5 ± 256.2 295.2 ± 127.4 
    Carbohydrates (% of kcal/day) 53.7 ± 8.7 53.1 ± 7.2 54.1 ± 9.5 
    Protein (g) 85.6 ± 50.1  84.1 ± 39.0 86.3 ± 55.5 
    Protein (% of kcal/day) 14.9 ± 3.4 14.3 ± 3.4 15.3 ± 3.4 
Predicted VO2peak (ml/kg/min) 30.0 ± 6.3 30.7 ± 5.7 29.2 ± 6.8 
Physical activity  
(% of time during 1 week) 
   
    Sedentary (%) 64.3 ± 7.5 62.4 ± 4.3 65.4 ± 8.7 
    Light (%) 9.1 ± 1.7 10.0 ± 1.5 8.5 ± 1.6 
    Lifestyle (%) 13.2 ± 2.9 14.0 ± 2.2 12.7 ± 3.2 
   Moderate (%) 13.5 ± 4.3 13.7 ± 2.5 13.3 ± 5.0 
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4.4.2  Neonatal Outcomes  
Cord blood could not be obtained for seven participants. Neonatal anthropometrics were not 
obtained for one participant. Neonatal demographic characteristics were similar between 
neonates of lean and obese women. Neonatal data are shown in Table 4.3.   
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Table 4.3 Neonatal demographic characteristics for lean and obese pregnant women  
 All (N=50) 
mean ± SD 
Lean (n=18) 
mean ± SD 
Obese (n=32) 
mean ± SD 
Gestational age at delivery 
(wks) 
39.2 ± 1.2  39.1 ± 0.9 39.3 ± 1.4 
Gestation age during 
anthropometric 
measurements (wks) 
39.4 ± 1.2 39.6 ± 1.1 39.6 ± 1.3 
Birth weight (g) 3272 ± 438 3221 ± 376 3301 ± 472 
Body fat (%) 11.5 ± 3.6 11.1 ± 4.3 11.7 ± 3.3 
Length (cm) 49.6 ± 2.2 49.5 ± 1.1 49.7 ± 2.2 
Head circumference (cm) 34.1 ± 1.4 33.7 ± 1.7 34.3 ± 1.2 
 # of neonates (%) # of neonates (%) # of neonates (%) 
Gender 
     Boy 
     Girl  
 
26 (52%) 
24 (48%) 
 
7 (39%) 
11 (61%) 
 
19 (59%) 
13 (41%) 
Mode of delivery 
      Vaginal 
      Cesarean section  
 
34 (68%) 
16 (32%) 
 
14 (78%) 
4 (22%) 
 
20 (63%) 
12 (37%) 
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4.4.3  Relationships between Maternal Metabolic Health and Neonatal 
Outcomes  
Maternal and neonatal metabolic outcomes were not related to each other, even when accounting 
for potential confounders. Table 4.4 shows correlations between primary maternal and neonatal 
metabolic outcomes. Neonatal glucose concentration was significantly higher in women who 
delivered vaginally versus a cesarean section (vaginal: 88.6 ± 16.8mg/dL vs. cesarean: 77.7 ± 
8.3mg/dL, p=0.008). Therefore, mode of delivery was accounted for when examining 
relationships between maternal and neonatal glucose, insulin, and HOMA-IR using a partial 
correlation controlling for mode of delivery. 
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Table 4.4 Relationships between maternal and neonatal metabolic outcomes  
 Maternal 
 
mean ± SD 
Neonatal 
 
mean ± SD 
Correlation 
between maternal 
& neonatal 
(R value, p-value) 
BMI (maternal)/ Ponderal 
Index (neonatal) 
30.2 ±  7.5 2.7 ± 0.3 r= 0.02, p=0.91 
Body fat (%) 31.2 ± 8.8 11.5 ± 3.6 r= 0.03, p=0.84 
C-reactive protein (mg/L) 5.7 ± 4.0 0.21 ± 0.15 r= 0.12, p=0.46 
Free fatty acids (meq/L) 0.47 ± 0.14 0.17 ± 0.07 r= -0.05, p=0.97 
Glucose (mg/dL) 79.1 ± 7.3 85.8 ± 15.7 r= 0.21, p=0.19 
Insulin (uU/mL) 15.4 ± 8.8 8.0 ± 5.6 r= 0.13, p=0.41 
HOMA-IR 3.1 ± 1.9 1.7 ± 1.4 r= 0.09, p=0.59 
*p<0.05 
 
 
 
 
 
 
 
 
120 
 
 Maternal lipid metabolism (lipid oxidation rate and lipolysis) was not related to neonatal 
metabolic outcomes. Relationships between maternal lipid metabolism and neonatal outcomes 
can be found in Table 4.5.  
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Table 4.5 Relationships between maternal lipid oxidation rate and lipolysis and neonatal 
metabolic outcomes 
 Maternal lipid oxidation rate 
(g/min) 
mean± SD 
Maternal lipolysis 
(meq·min/L) 
mean± SD 
Maternal value  0.11 ± 0.03 39.7 ± 10.2 
 
 
 
Neonatal outcome  
Correlation between maternal 
lipid oxidation rate and 
neonatal outcome 
(r, p-value) 
Correlation between 
maternal lipolysis and 
neonatal outcome 
(r, p-value) 
     Body fat (%) r= -0.003, p=0.99 r= -0.23, p=0.13 
     HOMA-IR r=0.10, p=0.52 r= 0.04, p=0.83 
     CRP (mg/L) r=0.13, p=0.43 r= -0.09, p=0.60 
     Free fatty acids (meq/L) r=0.15, p=0.35 r= -0.03, p=0.87 
*p<0.05 
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4.4.4  Additional Findings across all BMI Categories 
There was a trend for neonatal HOMA-IR to be correlated with neonatal body fat percentage 
(r=0.30, p=0.07) (Figure 4.1).  
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Figure 4.1 Relationship between neonatal body fat percentage and neonatal HOMA-IR 
 
 
 
 
 
 
 
 
 
r=0.30 
p=0.07 
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4.4.5  Relationships between Maternal and Neonatal Outcomes separated by 
BMI  
In lean pregnant women, maternal pre-pregnancy BMI was positively associated with neonatal 
body fat percentage (r=0.65, p=0.008). However, in obese pregnant women, maternal pre-
pregnancy BMI trended towards a negative correlation with neonatal body fat percentage (r=-
0.34, p=0.058). These trends did not change when accounting for gestational weight gain, which 
has been shown to influence the relationship between maternal BMI and neonatal birthweight 
and body composition35.  
 
In lean pregnant women, maternal lipid oxidation rate was significantly correlated with neonatal 
insulin (r=0.68, p=0.005) and neonatal HOMA-IR (r=0.64, p=0.006). These relationships did not 
exist among obese pregnant women.  
 
4.5 Discussion 
Contrary to our hypotheses, maternal lipid metabolism, insulin resistance, and inflammation 
were not related to neonatal adiposity, insulin resistance, and inflammation. Thus, maternal 
metabolic health does not appear to have an acute impact on neonatal metabolic outcomes. Our 
negative findings suggest that in a cohort of both lean and obese pregnant women, the fetus 
appears to be protected acutely from maternal metabolic perturbations experienced during 
pregnancy. However, the “fetal origins hypothesis” suggests that the origins of adult health 
diseases such as obesity, cardiovascular disease, and diabetes may be caused by in utero 
exposures, and that the programming of poor metabolic health may remain latent for years1,36. 
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Therefore, it is plausible that metabolic abnormalities may be epigenetically programmed, but 
are not apparent or measurable until later in life. To elaborate, physiologic variations may be 
present that could turn particular genes on and off and effect how genes are read without a 
change in the actual DNA sequence; thus, changes may be “programmed” but not actually 
measurable at birth. Long-term offspring follow-up is needed to draw definitive conclusions. 
 
4.5.1  Maternal and Neonatal Insulin Resistance 
The lack-of correlation between maternal and neonatal insulin resistance is inconsistent with 
previous studies in lean and obese women21. Catalano et al. demonstrated a positive correlation 
between maternal and neonatal insulin resistance in a cohort of lean and obese pregnant 
women21. A possible explanation for the contrary findings could be explained by the labor and 
delivery process endured by the study participants. Catalano et al. only measured maternal and 
neonatal HOMA-IR in women who presented to labor and delivery for an elective cesarean 
delivery; therefore, they did not undergo the process of labor. Most women included in the 
present study underwent labor prior to either mode of delivery, which may have impacted both 
maternal and neonatal blood glucose and insulin levels. In addition, we included neonates of 
vaginal deliveries. It has been shown that neonates whom were delivered vaginally have lower 
neonatal glucose concentrations37, which we also found in the present study.  Because neonatal 
HOMA-IR is largely determined by neonatal glucose levels, it is possible altered neonatal 
glucose concentrations due to mode of delivery contributed to our contradictory findings. In 
addition, Catalano et al. measured maternal HOMA-IR upon presentation to labor and delivery 
between 37 and 40 weeks, while we measured maternal HOMA-IR between 32-37 weeks 
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gestation. Because insulin resistance increases until the end of gestation8, this may also help 
explain the inconsistent findings.  
 
4.5.2  Maternal BMI, Body Composition, and Neonatal Body Composition 
Contrary to the literature38, we did not find a significant association between maternal pre-
pregnancy BMI or late gestation body fat percentage and neonatal body fat percentage in the 
combination of lean and obese pregnant women. Interestingly, when examining the relationship 
between maternal pre-pregnancy BMI and neonatal adiposity in lean women only, we found a 
strong positive correlation consistent with the literature. However, in exclusively obese women, 
we noted a moderate negative correlation. Although obesity is traditionally believed to contribute 
to larger babies39-41, obesity has been shown to increase the risk for small-for-gestation-age 
neonates as well42,43. It is possible that in our cohort of obese women, the negative relationship 
could indicate an increased risk for small-for-gestation-age neonates. Similar to macrosomic 
neonates, small-for-gestation-age neonates are also at-risk for poor long-term health 
outcomes40,42,44,45. The notion that obesity might increase risk for small-for-gestation-age 
neonates may also help explain the lack-of-association between maternal pre-pregnancy BMI 
and neonatal adiposity across all groups in our study.  
 
Another possible explanation for not finding a relationship between maternal pre-pregnancy BMI 
and neonatal body fat percent could be related to the study population. Previous studies by 
Starling et al. and Hull et al. (two studies that found a positive relationship between maternal 
BMI and neonatal body fat percent) did include women of a wide range of body mass indexes; 
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however, only 20% and 12%, respectively, were classified as obese (BMI ≥30kg/m2)38,46. Our 
cohort consisted of 64% obese pregnant women. These findings indicate a greater need for 
analyzing the impact on pre-pregnancy BMI on neonatal adiposity in exclusively obese women. 
Several studies have analyzed the relationships between maternal BMI and neonatal birthweight 
in obese women40-42,47,48, but literature on pre-pregnancy BMI and neonatal adiposity, 
particularly using high-quality measurements such as air displacement plethysmography 
technology, is limited38,46,49.   
 
4.5.3  Maternal and Neonatal Inflammation 
The current study did not find an association between maternal and neonatal inflammation. Most 
cytokines do not cross the placenta; thus, our results support the concept that maternal 
inflammation does not directly transfer across the placenta and lead to fetal inflammation21,50.  It 
is possible that neonates may be “programmed” for higher systemic inflammation or other poorer 
outcomes later in life. In support of this concept, Leibowitz et al. found that offspring of obese 
women had higher inflammatory markers at 12 years of age51.  Despite a number of neonatal 
risks associated with maternal inflammation52, we do not yet understand the connection, if any, 
between maternal and neonatal inflammation. 
 
4.5.4  Maternal Lipid Metabolism and Neonatal Outcomes 
We found no associations between maternal lipid metabolism and neonatal outcomes including 
adiposity, insulin resistance, and inflammation. Crume et al. found that maternal circulating 
lipids during the second half of pregnancy predicted higher neonatal birth weight23. In our study, 
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maternal plasma free fatty acid concentration as well as maternal lipid oxidation and lipolysis did 
not relate to any neonatal outcomes. However, our data were collected at different time points 
than Crume et al. making it difficult to compare results considering lipid metabolism changes 
throughout pregnancy15.  
When lean pregnant women were analyzed independently, maternal lipid oxidation was 
significantly correlated with neonatal insulin concentration and neonatal HOMA-IR. However, 
these relationships did not exist among obese pregnant women. These data indicate that 
mechanisms contributing to neonatal insulin and insulin resistance may differ based on pre-
pregnancy BMI status, and that lipid metabolism may play a more significant role in determining 
neonatal insulin resistance in lean women. The reason for these differences is unclear.  
 
4.5.5  Neonatal Adiposity and Insulin Resistance 
In our study, we noted a trend for neonatal HOMA-IR to be positively correlated with neonatal 
body fat percentage. Similarly, Catalano at el. concluded that neonatal body fat percentage was 
positively correlated to neonatal insulin resistance21. This finding suggests that the known 
relationship between body fat percentage and insulin resistance in non-gravid adults53 appears to 
exist very early in life.  
 
4.5.6  Limitations 
The present study results are based strictly on relationships between maternal and neonatal 
outcomes; therefore, most of our findings, and the interpretations of those findings, are 
speculative. The lack-of associations between maternal and neonatal outcomes, and the 
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associations between outcomes in obese and lean women when separated, elucidate the 
complexity of examining the role of maternal health status during pregnancy and neonatal health 
at delivery. We also had a small sample size of 50 participants, thus, larger numbers may be 
needed to detect significant relationships.  
4.5.7  Conclusions 
We found no associations between maternal lipid metabolism, insulin resistance, and 
inflammation, and neonatal adiposity, insulin resistance, and inflammation across all participants.  
Long-term follow up is needed to determine the long-term effects of maternal metabolic health 
on childhood metabolic health. The relationships between maternal and neonatal metabolic 
health are complex and might be dependent on maternal BMI status.  
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Chapter 5: Low-Intensity Physical Activity is 
Associated with Maternal Systemic 
Inflammation during Late Pregnancy 
 
 
 
 
 
 
 
 
 
 
 
This chapter is in preparation for submission to the Journal of Applied Physiology, Nutrition, and 
Metabolism.   
Tinius RA, Cade WT. Low-intensity physical activity is associated with systemic inflammation 
during late pregnancy.  
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5.1 Abstract 
 
Background: Excessive maternal inflammation during pregnancy increases the risk for maternal 
and neonatal metabolic complications; however, maternal physical activity during pregnancy 
appears to reduce maternal inflammation. The purpose of this study is to examine the 
relationship between maternal physical activity intensity and maternal inflammation during late 
pregnancy.  
Methods: Maternal physical activity levels (sedentary, light, lifestyle, and moderate), fitness 
levels, and systemic inflammation (plasma C-reactive protein (CRP) concentration) were 
measured between 32-37 weeks gestation.  
Results: Maternal plasma CRP was negatively associated with time spent in light and lifestyle 
physical activities (Light: r= -0.40, p= 0.01; Lifestyle: r= -0.31, p= 0.03), but not with time spent 
in moderate physical activity (r= -0.18, p= 0.21). Higher maternal plasma CRP tended to 
correlate with more time spent sedentary (r= 0.27, p= 0.06). We also noted that small daily 
increases in light and lifestyle activities could elicit a clinically meaningful change in 
inflammation.  
Conclusions: Pregnant women should be encouraged to incorporate more low-intensity physical 
activities into their daily routines in order to decrease systemic maternal inflammation and 
potentially improve maternal and neonatal pregnancy outcomes.  
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5.2 Introduction 
Low-grade chronic inflammation, often secondary to obesity, plays an important role in the 
pathogenesis of many chronic diseases including metabolic syndrome, cardiovascular disease, 
diabetes, and hypertension1-4. During pregnancy, maternal systemic inflammation is 
physiologically elevated5,6. Excessive inflammation during pregnancy however increases the risk 
for metabolic complications such as insulin resistance/gestational diabetes and 
hypertension/preeclampsia6-8. Increased inflammation might also increase risk for future 
maternal disease including metabolic syndrome, insulin resistance, diabetes, hypertension, and 
cardiovascular disease9.  Maternal inflammatory changes during pregnancy appear to extend into 
the placenta potentially exposing the fetus to an inflammatory environment during 
development10, which might contribute to preterm delivery, infection, and the programming of 
adult metabolic disease6,11,12.  
 
Light and vigorous maternal physical activities during pregnancy are associated with lower 
systemic inflammation in the second trimester13,14.  However, the relationship between physical 
activity intensity and maternal inflammation in late pregnancy is unclear. The purpose of this 
study is to examine the relationship between physical activity intensity and inflammation during 
late pregnancy. 
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5.3 Methods 
 
5.3.1  Participants 
Fifty women pregnant women participated in the present study (N=50).  
 
5.3.2  Study Procedures 
Pre-pregnancy body mass index (BMI) was calculated at initiation of prenatal care or via self-
report if presentation for care was >10 weeks gestation. All other measures were taken at 32-37 
weeks gestation. Body composition was measured using 7-site skinfold anthropometry 
(Harpenden Skinfolds Caliper, Baty International, United Kingdom)15. Fitness levels were 
assessed using the YMCA submaximal cycle test on a recumbent bicycle (Lode Corvial 
Recumbant, Lode B.V., The Netherlands). In addition, maternal physical activity levels were 
assessed for one week one using the ActiGraph GT3X+ accelerometer (ActiGraph LLC, 
Pensacola, FL). The Actigraph was placed on the non-dominant wrist with non-removable 
wristbands. ActiGraph data was collected for seven consecutive days at 30 Hertz (compliance for 
the present study was 100% as all 50 women wore the wristband for all seven days). The 
percentage of time spent sedentary as well as the amount of time spent participating in different 
categories of physical activity ranging from light and lifestyle to moderate were calculated using 
algorithms corresponding to the following activity counts: sedentary: 0 - 99 counts/min, light: 
100 - 759 counts/min, lifestyle: 760 - 1951 counts/min, moderate: 1952-5724  counts/min16.  
Inflammation was measured via fasting plasma concentration of high-sensitivity C-reactive 
protein (CRP). CRP was measured by immunoturbidimetric assay (Roach Diagnostics, 
Indianapolis, IN).  
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5.3.3  Statistical Analysis 
Maternal CRP was not normally-distributed. Thus, Spearman’s rank order correlation 
coefficients were used to assess the degree of relationships between CRP and all other variables. 
Additionally, Student’s independent t-tests were used to compare time spent in low-intensity 
activities (light or lifestyle) between those who are at risk for cardiovascular disease based on the 
established cut-off of a CRP value ≥3.0mg/L (≥3.0mg/L represents higher risk for cardiovascular 
disease17) and those who were not. Logistic regression was also used to determine the amount of 
physical activity necessary to reduce the odds of having a CRP value ≥3.0mg/L.  
 
5.4 Results 
5.4.1  Maternal Demographics and Metabolic Characteristics 
Maternal demographic and metabolic data can be found in Table 5.1.  
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Table 5.1. Maternal demographic and metabolic characteristics 
 Mean ± SD  
Age (y) 26.6 ± 5.0 
Pre-pregnancy BMI (kg/m2) 30.2  ± 7.5 
Body fat (%) 31.2 ± 8.8 
Resting systolic blood pressure (mmHg) 110.2 ± 9.4 
Resting diastolic blood pressure (mmHg) 70.0 ± 6.8 
Resting heart rate (bpm) 87.4 ± 10.8 
Gestational weight gain (kg) 11.8 ± 7.1 
C-reactive protein (mg/L) 5.7 ± 4.0 
Predicted VO2peak (ml/kg/min) 29.7 ± 6.4 
 # of women (%) 
Race 
     African-American 
     Caucasian 
     Other 
 
26 (52%) 
21 (42%) 
 3  ( 6%) 
Parity 
     Nulliparous 
    Multiparous 
 
28 (56%) 
22 (44%) 
Income  
     Low 
     Moderate-to-high 
 
23 (46%) 
27 (54%) 
Physical activity levels (% /week) 
     Sedentary 
     Light 
     Lifestyle 
     Moderate 
 
64.3 ± 7.5 
9.1 ± 1.7 
13.1 ± 2.9 
13.5 ± 4.3 
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5.4.2  Relationship between CRP and Physical Activity  
Maternal plasma CRP concentration was associated with maternal body fat percentage at 32-37 
weeks (r= 0.70, p<0.001).  Higher maternal fitness levels were associated with lower maternal 
plasma inflammation (r= -0.30, p= 0.03). Higher maternal plasma CRP concentration tended to 
correlate with more time spent sedentary (r=0.27, p= 0.06).Maternal plasma CRP was negatively 
associated with time spent in light and lifestyle physical activities (Light: r= -0.40, p= 0.01; 
Lifestyle: r= -0.31, p= 0.03); CRP was not correlated with time spent in moderate physical 
activity (r= -0.18, p= 0.21). Correlations are shown in Figure 5.1.  
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Figure 5.1 Maternal inflammation (CRP) in relation to maternal body composition (A), fitness 
levels (B), and physical activity levels (C-F).   
 
143 
 
There were no differences in CRP between the women who only walked and the women who 
walked in conjunction with other modes of exercise such as biking, swimming, yoga, and 
weight-lifting (6.2 ± 3.1 mg/L versus 6.3 ± 1.9 mg/L, p= 0.94).   
 
The amount of time spent in low-intensity physical activities (light and lifestyle variables were 
combined) was 24.4 ± 3.8% (351 minutes) for women with a CRP value <3.0mg/dL versus 21.1 
± 4.4% (304 minutes) for women who had a CRP value ≥3.0mg/L (p=0.02). The odds of having 
CRP≥3.0mg/L were reduced by 16% for every additional 14 minutes per day of low-intensity 
physical activity (Exp(B)=0.84, 95% CI [0.72-0.98], p=0.03).  
 
5.5 Discussion 
The primary finding of our study is that time spent in light and lifestyle physical activities during 
late pregnancy is associated with lower maternal systemic inflammation. To our knowledge, this 
is the first study to show relationships between low-intensity maternal physical activity and 
maternal systemic inflammation during late pregnancy. Our results are consistent with Hawkins 
et al. who found that light-intensity physical activity had a negative association with CRP among 
women in their second trimester13. Understanding the relationships between physical activity 
intensity and inflammation during late pregnancy (i.e. the present study) is imperative as women 
are most likely to decrease their physical activity levels near the end of gestation18. In addition, 
our study examined these relationships in a cohort of predominantly obese women, which is 
important because these women are at the highest risk for excessive maternal inflammation and 
its downstream sequela19.   
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In addition to the negative correlation between maternal light and lifestyle physical activity and 
maternal inflammation, we also found that more time spent sedentary during pregnancy tended to 
be associated with higher maternal systemic inflammation. Surprisingly, there was not a 
significant relationship between time spent in moderate physical activity and inflammation. 
Taken together, our data suggest that low-intensity physical activity may reduce inflammation in 
pregnant women, and that decreasing time spent sedentary and increasing low-intensity activities 
may be enough of a stimulus to elicit reductions in maternal systemic inflammation. Our findings 
also suggest that more intense physical activities such as swimming, cycling, and weight-lifting 
might not  necessarily be superior to walking during pregnancy in terms of lowering maternal 
inflammation; however more research in necessary to confirm this. 
 
Based on the present study, we believe pregnant women should be encouraged to increase 
physical activity during day-to-day tasks (e.g. taking the stairs, parking further away, walking 
instead of driving) in order to reduce systemic inflammation late in pregnancy. Not only do these 
types of lifestyle changes appear to elicit reductions in maternal systemic inflammation, but they 
are easier for pregnant women to adopt compared to structured exercise programs. In fact, the 
most commonly reported barriers to physical activity during pregnancy are lack of time, 
employment obligations, childcare responsibilities, fatigue, and pregnancy-related discomfort20-
24
. Incorporating less sedentary time and more low-intensity physical activities into daily routines 
might help women overcome these barriers as these modifications do not involve large time 
commitments (e.g. does not require a blocked-off period of time to go the gym); they can be 
performed in the workplace (e.g. take the stairs at work, use a standing desk, take frequent breaks 
at work to walk); they can be done with children (e.g. playing in the yard with other kids or pets, 
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going for a slow walk with a stroller or wagon, walking around a store); and they are not overly 
fatiguing activities that may be uncomfortable during late pregnancy.  
 
Upon further analysis, our data suggest that spending an additional 14 minutes per day during 
late pregnancy in low-intensity (i.e. light or lifestyle) physical activities may reduce the odds of 
having a CRP value over the clinical threshold of 3.0mg/L by 16%. In addition, pregnant women 
with CRP values below this clinical threshold spent on average only 47 additional minutes per 
day doing light and lifestyle activities than those who were above this clinical value. Therefore, 
even small daily increases in light and lifestyle activities could elicit a clinically meaningful 
change in inflammation.  
 
Therefore, it appears that pregnant women should be encouraged to become more physically 
active in order to improve their inflammation levels, and ultimately their metabolic health and 
the future health of their neonate.  
 
5.5.1  Conclusions 
Maternal inflammation is related to low-intensity physical activities (light, lifestyle) but not 
moderate intensity activities. Pregnant women should consider incorporating low-intensity 
physical activities into their daily routines in order to improve markers of inflammation. 
146 
 
5.6 References 
1. Yang T, Chu CH, Hsieh PC, et al. C-reactive protein concentration as a significant 
correlate for metabolic syndrome: a Chinese population-based study. Endocrine. Apr 
2013;43(2):351-359. 
 
2. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Inflammation 
and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance 
Atherosclerosis Study. Kidney Int. Oct 2000;58(4):1703-1710. 
 
3. Ridker PM, Bassuk SS, Toth PP. C-reactive protein and risk of cardiovascular disease: 
evidence and clinical application. Curr Atheroscler Rep. Sep 2003;5(5):341-349. 
 
4. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy 
subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a 
potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc 
Biol. Apr 1999;19(4):972-978. 
 
5. Watts DH, Krohn MA, Wener MH, Eschenbach DA. C-reactive protein in normal 
pregnancy. Obstet Gynecol. Feb 1991;77(2):176-180. 
 
6. Schmatz M, Madan J, Marino T, Davis J. Maternal obesity: the interplay between 
inflammation, mother and fetus. J Perinatol. Jul 2010;30(7):441-446. 
 
7. Ozgu-Erdinc AS, Yilmaz S, Yeral MI, Seckin KD, Erkaya S, Danisman AN. Prediction 
of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, 
fasting plasma glucose, insulin and insulin sensitivity indices. J Matern Fetal Neonatal 
Med. Oct 28 2014:1-6. 
 
8. Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin 
Fetal Neonatal Med. Oct 2006;11(5):309-316. 
 
9. Kosus N, Kosus A, Turhan N. Relation between abdominal subcutaneous fat tissue 
thickness and inflammatory markers during pregnancy. Archives of medical science : 
AMS. Aug 29 2014;10(4):739-745. 
 
10. Challier JC, Basu S, Bintein T, et al. Obesity in pregnancy stimulates macrophage 
accumulation and inflammation in the placenta. Placenta. Mar 2008;29(3):274-281. 
 
11. Barker DJ. The developmental origins of adult disease. J Am Coll Nutr. Dec 2004;23(6 
Suppl):588S-595S. 
 
12. Segovia SA, Vickers MH, Gray C, Reynolds CM. Maternal obesity, inflammation, and 
developmental programming. BioMed research international. 2014;2014:418975. 
 
147 
 
13. Hawkins M, Pekow P, Chasan-Taber L. Physical activity, sedentary behavior, and C-
reactive protein in pregnancy. Med Sci Sports Exerc. Feb 2014;46(2):284-292. 
 
14. Wang Y, Cupul-Uicab LA, Rogan WJ, et al. Recreational Exercise Before and During 
Pregnancy in Relation to Plasma C-Reactive Protein Concentrations in Pregnant Women. 
J Phys Act Health. Aug 7 2014. 
 
15. Jackson AS, Pollock ML, Ward A. Generalized equations for predicting body density of 
women. Med Sci Sports Exerc. 1980;12(3):175-181. 
 
16. Freedson PS, Melanson E, Sirard J. Calibration of the Computer Science and 
Applications, Inc. accelerometer. Med Sci Sports Exerc. May 1998;30(5):777-781. 
 
17. Oda E, Oohara K, Abe A, et al. The optimal cut-off point of C-reactive protein as an 
optional component of metabolic syndrome in Japan. Circ J. Apr 2006;70(4):384-388. 
 
 
18.       Borodulin KM, Evenson KR, Wen F, Herring AH, Benson AM. Physical activity patterns  
during pregnancy. Med Sci Sports Exerc. Nov 2008;40(11):1901-1908. 
 
19. Christian LM, Porter K. Longitudinal changes in serum proinflammatory markers across 
pregnancy and postpartum: effects of maternal body mass index. Cytokine. Dec 
2014;70(2):134-140. 
 
20. Evenson KR, Moos MK, Carrier K, Siega-Riz AM. Perceived barriers to physical activity 
among pregnant women. Matern Child Health J. May 2009;13(3):364-375. 
 
21. Leiferman J, Swibas T, Koiness K, Marshall JA, Dunn AL. My baby, my move: 
examination of perceived barriers and motivating factors related to antenatal physical 
activity. Journal of midwifery & women's health. Jan-Feb 2011;56(1):33-40. 
 
22. Cramp AG, Bray SR. A prospective examination of exercise and barrier self-efficacy to 
engage in leisure-time physical activity during pregnancy. Annals of behavioral medicine 
: a publication of the Society of Behavioral Medicine. Jun 2009;37(3):325-334. 
 
23. Cioffi J, Schmied V, Dahlen H, et al. Physical activity in pregnancy: women's 
perceptions, practices, and influencing factors. Journal of midwifery & women's health. 
Sep-Oct 2010;55(5):455-461. 
 
24. Marshall ES, Bland H, Melton B. Perceived barriers to physical activity among pregnant 
women living in a rural community. Public Health Nurs. Jul 2013;30(4):361-369. 
 
 
148 
 
 
 
Chapter 6: Conclusions 
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6.1 Summary and Significance of Key Findings 
The primary purposes of this dissertation were to (1) compare maternal lipid metabolism, 
maternal inflammation, maternal insulin resistance, and neonatal metabolic health between lean 
and obese pregnant women, (2) determine if a physically active lifestyle during pregnancy was 
associated with improved maternal lipid metabolism, lower maternal inflammation, lower 
maternal insulin resistance, and better neonatal metabolic health in obese women during late 
pregnancy, and to (3) determine the relationships between maternal and neonatal metabolic 
health. 
 
6.1.1  Chapter 2 
The primary purposes of Chapter 2 were to compare lipid oxidation rate and lipolysis during late 
pregnancy between obese and lean women, and to examine the relationships between maternal 
lipid metabolism, inflammation and insulin resistance.  We found that obese pregnant women 
have higher mean lipid oxidation rate, particularly following an acute bout of low-intensity 
exercise. In addition, higher maternal lipid oxidation rate was associated with higher maternal 
inflammation. This is consistent with data in non-gravid adults that demonstrates lipid oxidation 
is related to inflammation1. The current study also found that higher maternal inflammation was 
associated with higher insulin resistance, suggesting that maternal inflammation, possibly the 
result of greater lipid oxidation, might contribute to higher maternal insulin resistance in obese 
pregnant women. Our results are consistent with Retnakaran et al. who demonstrated that obesity 
during pregnancy elicits an inflammatory response with possible downstream metabolic sequela 
including insulin resistance2.  
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Although not a primary focus of the study, we also found that higher maternal inflammation was 
associated with greater resting systolic blood pressure. High blood pressure disorders during 
pregnancy, including preeclampsia, are an important cause of morbidity, long-term disability, 
and even death among pregnant women and their offspring3. Inflammation has been identified as 
a key contributor to pregnancy-specific high blood pressure4,5 and our findings are consistent 
with this.  
 
Therefore, Chapter 2 demonstrated that obese pregnant women have altered lipid metabolism, 
and this alteration might contribute to higher maternal inflammation, insulin resistance and blood 
pressure. Clinically, these findings are important as insulin resistance (gestational diabetes 
mellitus) and high blood pressure (hypertension or preeclampsia) are two major contributors to 
perinatal complications in obese pregnant women. Our study suggests that inflammation-related 
alterations in lipid metabolism might be a contributing factor toward these unfavorable 
pregnancy outcomes.  
 
6.1.2  Chapter 3 
The primary purpose of Chapter 3 was to compare maternal inflammation between physically 
active and sedentary obese women during pregnancy.  We found that inflammation was lower in 
physically active obese pregnant women when compared to sedentary obese pregnant women. 
To our knowledge, this is the first study to demonstrate that physical activity might reduce 
inflammation in obese pregnant women. Chapter 3 also examined the relationships between 
maternal inflammation and maternal lipid metabolism. Alterations in lipid metabolism (i.e. 
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higher lipolysis and higher plasma free fatty acid concentration) among obese women might be 
contributing to inflammation as measures of lipid metabolism and inflammation were related. 
Interestingly, this relationship appeared to be driven primarily by the obese-sedentary group as 
lipid oxidation and inflammation were positively correlated in obese-sedentary women, but this 
relationship did not exist in obese active women. Therefore, it is plausible that the reason for the 
lack-of association between lipid oxidation and inflammation in the obese active group was due 
to obese active women having improved efficiency of lipid metabolism resulting in complete 
oxidation of lipids, lower oxidative stress, and lower systemic inflammation. However, because 
reactive oxygen species or intermediate by-products of lipid metabolism were not measured, this 
is speculative.  Lastly, neonatal metabolic outcomes were not different between active and 
sedentary obese pregnant women, but long-term follow-up is needed to examine potential long-
term effects of physical activity on offspring health.  
 
6.1.3  Chapter 4 
The purpose of Chapter 4 was to examine the relationships between late pregnancy maternal and 
neonatal health in lean and obese women. We found no associations between maternal lipid 
metabolism, insulin resistance, and inflammation and neonatal adiposity, insulin resistance, and 
inflammation across all participants. Although we did not find any significant relationships 
between maternal and neonatal metabolic health, based on other longitudinal studies, maternal 
metabolism might have induced epigenetic changes that are not evident until later in the child’s 
life6.  Long-term follow up is needed to determine potential long-term effects of maternal 
metabolic health on childhood metabolic health.  
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Several relationships between maternal and neonatal metabolic health were found when 
examining obese and lean women independently. This may highlight the complexity of 
understanding the relationships between maternal and neonatal metabolic health in women of 
varying body compositions.  
 
6.1.4  Chapter 5 
The purpose of Chapter 5 was to examine the relationship between maternal physical activity 
intensity and maternal inflammation during late pregnancy. Maternal plasma inflammation was 
negatively associated with time spent in light and lifestyle physical activities, but not with time 
spent in moderate physical activity. Higher maternal plasma inflammation tended to correlate 
with more time spent sedentary. Higher maternal fitness level was associated with lower 
maternal plasma inflammation. Overall, our data suggest that low-intensity physical activity 
might reduce inflammation in pregnant women, and that decreasing time spent sedentary and 
increasing low-intensity activities may be enough of a stimulus to elicit reductions in maternal 
systemic inflammation. Our findings also suggest that more intense physical activities such as 
swimming, cycling, and weight-lifting might not necessarily be superior to walking during 
pregnancy in terms of lowering maternal inflammation.  Therefore, we believe pregnant women 
should be encouraged to become more physically active in order to reduce inflammation levels 
and improve their metabolic health and the future health of their neonate. Low-intensity activities 
that are enjoyable and can be easily incorporated into their everyday lives should be 
recommended.  
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6.1.5  Overall Conclusions 
Overall, this dissertation suggests that maternal lipid metabolism, inflammation, and insulin 
resistance are related to each other and altered in obese pregnant women. However, obese 
pregnant women that engage in physical activity have lower systemic inflammation which is 
associated with better maternal metabolic health.  Despite the influences of obesity and physical 
activity on maternal health, none of these metabolic alterations appeared to directly translate into 
immediate changes in neonatal metabolic outcomes. However, long-term follow-up is needed to 
better address whether or not obesity and/or physical activity during pregnancy had a long-term 
impact on the health of the offspring. In addition, we found that low-intensity physical activities 
may be enough of a stimulus to reduce inflammation in lean and obese women. Taken together, 
this dissertation suggests that obese pregnant women should engage in physical activity, even 
low-intensity activities, in order to reduce their inflammation and potentially improve their 
health and the health of their offspring.  
 
6.2 Limitations 
This dissertation project had several potential limitations including: 1) cross-sectional study 
design, 2) small sample size, and 3) potential bias during data collection. Although it was 
prospective, this observational, cross-sectional study could only look at the relationships between 
groups and between outcomes, and thus, could not determine cause and effect. Second, this study 
was powered based on primary outcomes for each aim, thus, examination of other variables 
might have been underpowered. Lastly, bias may have been introduced because measurements 
and assessments were not blinded as women were recruited based on what group they were 
assigned to (i.e. it was obvious who was lean versus obese-sedentary versus obese-active).  
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Uniform data collection procedures were followed for all participants to minimize bias and data 
were objective in nature. In addition, all maternal and neonatal data collections were performed 
by the same person to minimize interpersonal variability, which can be particularly important 
with anthropometric measurements such as skinfolds.  
 
6.3 Future Directions 
 
6.3.1  Oxidative Stress 
One future direction of the proposed line of research is to examine the role of maternal lipid 
metabolism-mediated oxidative stress on inflammation, insulin resistance, and neonatal 
metabolic health. Changes in maternal oxidative stress might provide a link between increased 
maternal lipid oxidation, inflammation, and subsequent insulin resistance and hypertension in 
obese pregnant women. In non-gravid adults, oxidative stress is elevated in obesity7 and is 
associated with inflammation, vascular cell wall damage, high blood pressure, cardiovascular 
disease, poor metabolic function, and insulin resistance8-16. It is possible that elevated lipid 
oxidation rates observed in obese pregnant women might be the result of inefficient and 
incomplete substrate oxidation; thus, resulting in the generation of partially oxidized substrates 
(i.e. reactive oxygen species). Bell et al. concluded that incomplete, partial oxidation is increased 
in obesity17. Therefore, increased absolute lipid oxidation in pregnant obese women may be 
suggestive of increased incomplete oxidation, which may then be contributing to oxidative stress, 
and ultimately the inflammation and insulin resistance observed in the current study; however, 
this is speculative and requires further study. It is also well-established that exercise improves 
efficiency of lipid metabolism as well as combats oxidative stress18,19; therefore, physical activity 
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also has the potential to alter the relationships between lipid oxidation, inflammation, and 
oxidative stress. Figure 2.5 (Chapter 2) depicts the proposed pathway for the role of maternal 
lipid metabolism in long-term maternal and neonatal outcomes, and the potential role of 
oxidative stress in this pathway.  
 
6.3.2  The Effects of Physical Activity on Maternal and Neonatal Health 
Current guidelines recommend all pregnant women without contraindications participate in 30 
minutes or more of moderate-intensity, daily physical activity20. Despite the well-established 
benefits, only 23% of pregnant women engage in the recommended amounts of physical 
activity21. Obese women tend to be less active to begin with, and tend to further reduce their 
physical activity levels during pregnancy20. With maternal obesity rates increasing in 
concordance with increasing rates of obesity in the general population, studies that demonstrate 
both the safety and efficacy of physical activity in obese pregnant women are needed. This 
dissertation project provides the first evidence that maternal physical activity is beneficial in 
improving maternal inflammation in obese women during late pregnancy. Based on our findings, 
future studies need to assess the effect of physical activity on lipid metabolism, inflammation, 
and insulin resistance in randomized controlled clinical trials. In addition, future studies should 
also follow neonates born to obese and/or physically active women into childhood and adulthood 
to truly understand the long-term implications of obesity and physical activity on “fetal 
programming” and offspring health.  
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6.3.3  Dissemination of Physical Activity during Pregnancy Research 
In addition to the studies that demonstrate the safety and efficacy of physical activity in obese 
pregnant women, we also need dissemination tools in place to allow these messages to translate 
into the clinic and the community. Obese pregnant women report receiving little or no exercise 
advice from their health care provider22,23. Pregnancy can be considered a “teachable moment”, 
and thus, can be a powerful incentive to establish a healthy lifestyle24. With the obesity epidemic 
being a significant public health concern, research elucidating the causes of childhood and 
subsequent adult obesity, and the design and implementation of interventions to reduce it, are 
critical. 
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